sign in sign up
<<
Home , Ambutonium bromide, Betamethasone benzoate, Bromhexine, Carbocisteine, Clostebol acetate, Emepronium bromide

MEDICINES (PRESCRIPTION ONLY) (JERSEY) ORDER 1997

Revised Edition 20.625.95 Showing the law as at 1 January 2019 This is a revised edition of the law

Medicines (Prescription Only) (Jersey) Order 1997 Arrangement

MEDICINES (PRESCRIPTION ONLY) (JERSEY) ORDER 1997

Arrangement Article 1 Interpretation ...... 5 2 Prescription only medicines ...... 7 3 Medicinal products that are not prescription only medicines ...... 8 4 New medicinal products ...... 9 5 Appropriate practitioner ...... 9 6 Conditions for prescriptions relating to sale and supply ...... 9 6A Conditions for prescriptions – administration ...... 11 7 Exemption for highly diluted medicinal products ...... 11 8 Exemptions for specified categories of persons ...... 11 9 Exemption for emergency sale or supply...... 12 10 Exemption for sale or supply in hospitals or the prison...... 14 11 Exemption for authorised needle supply services ...... 14 12 Exemption for sale or supply in cases involving another’s default ...... 14 13 Exemption in the case of forged prescription ...... 14 14 Exemption for parenteral administration to human beings ...... 14 15 Exemption for non-parenteral administration to human beings ...... 15 16 Citation ...... 15

SCHEDULE 1 16

PART 1 16

PRESCRIPTION ONLY MEDICINES 16

PART 2 69

PART 3 70

NAMED PRODUCTS THAT ARE NOT PRESCRIPTION ONLY MEDICINES 70

TABLE A 70

Revised Edition – 1 January 2019 Page - 3 20.625.95

Arrangement Medicines (Prescription Only) (Jersey) Order 1997

TABLE B 71

PART 4 72

OTHER MEDICINAL PRODUCTS THAT ARE NOT PRESCRIPTION ONLY MEDICINES 72

SCHEDULE 2 85 EXEMPTION FOR CERTAIN PERSONS FROM ARTICLE 57(2) OF THE LAW 85

PART 1 85

PART 2 89

PART 3 91

SCHEDULE 3 94 SUBSTANCES THAT MUST NOT BE CONTAINED IN A PRESCRIPTION ONLY MEDICINE EXEMPTED BY ARTICLE 9 94

SCHEDULE 4 95

CLINICAL MANAGEMENT PLAN 95 1 Information to be included in clinical management plan ...... 95

Supporting Documents

ENDNOTES 96 Table of Legislation History ...... 96 Table of Renumbered Provisions ...... 96 Table of Endnote References ...... 98

Page - 4 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Article 1

MEDICINES (PRESCRIPTION ONLY) (JERSEY) ORDER 19971

THE HEALTH AND SOCIAL SERVICES COMMITTEE in pursuance of Articles 57 and 110 of the Medicines (Jersey) Law 19952, after consultation with the Medicines Advisory Council and having otherwise complied with Article 110 of the Law, orders as follows –

Commencement [see endnotes]

1 Interpretation (1) In this Order, unless the context otherwise requires – “aerosol” means a product that is dispersed from its container by a propellent gas or liquid; “controlled drug” has the same meaning as it has in Article 3 of the Misuse of Drugs (Jersey) Law 19783; “cyanogenetic substances” means preparations – (a) that are presented for sale or supply under the name of, or as containing, amygdalin, laetrile or vitamin B17; or (b) that contain more than 0.1% by weight of any substance having the formula α-cyanobenzyl-6-O-ß-D-glucopyranosyl-ß-D- glucopyranoside or α-cyanobenzyl-ß-D-glucopyranosiduronic acid; “dosage unit” means – (a) where a medicinal product is in the form of a tablet or capsule or is an article in some other similar pharmaceutical form, that tablet, capsule or other article; and (b) where a medicinal product is not in any such form, the quantity of the product that is used as the unit by reference to which the dose is measured; “external use” means application to the skin, hair, teeth, mucosa of the mouth, throat, nose, ear, eye, vagina or anal canal, when a local action

Revised Edition – 1 January 2019 Page - 5 20.625.95

Article 1 Medicines (Prescription Only) (Jersey) Order 1997

only is intended and extensive systemic absorption is unlikely to occur; but does not mean application by means of a throat spray, throat pastille, throat lozenge, throat tablet, nasal drop, nasal spray, nasal inhalation or teething preparation; “health prescription” means a prescription described in Article 15(2) of the Health Insurance (Jersey) Law 19674; “health record” has the same meaning as in the Data Protection (Jersey) Law 20185; “inhaler” does not include an aerosol; “Law” means the Medicines (Jersey) Law 19956; “master” has the same meaning as it has in the Merchant Shipping Act 1894 of the ; “maximum daily dose” or “MDD” means, in relation to a substance contained in the amount of a medicinal product for internal use, the recommended maximum quantity to be taken or administered in a period of 24 hours; “maximum dose” or “MD” means, in relation to a substance contained in the amount of a medicinal product for internal use, the recommended maximum quantity to be taken or administered at any one time; “maximum strength” means such of the following as may be specified – (a) the maximum quantity of a substance by weight or volume contained in a dosage unit of a medicinal product; (b) the maximum number of units of activity contained in a dosage unit or a weight of a medicinal product; and (c) the maximum percentage of a substance contained in a medicinal product calculated in terms of weight in weight, weight in volume, volume in weight or volume in volume, as appropriate; “medicinal product” does not include a veterinary drug; “occupational health scheme” means a scheme in which a person in the course of a business carried on by him or her provides facilities for his or her employees, for the treatment or prevention of disease; “operator”, in relation to an aircraft, means the person for the time being having the management of the aircraft; “parenteral administration” means administration by breach of the skin or mucous membrane; “prescription only medicine” means a medicinal product that is specified by this Order as a prescription only medicine; “registered optometrist” has the same meaning as it has in Article 1(1) of the Opticians (Registration) (Jersey) Law 19627; “repeatable prescription” means a prescription containing a direction that it shall or may be dispensed more than once; “soaps” means any compounds of a fatty acid with an alkali or amine;

Page - 6 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Article 2

“state registered paramedic” means a person who is registered in the register established and maintained under section 60 and paragraph 1(a) of Schedule 3 to the Health Act 1999 of the United Kingdom; “supplementary prescriber” means an appropriate practitioner referred to in Article 5(d), (e) or (f) whose entry on the register established and maintained under article 5 of the Nursing and Midwifery Order 2001 of the United Kingdom, as referred to in the Health Care (Registration) (Prescribed Qualifications) (Jersey) Order 20038, indicates that he or she is, or may act as, only a supplementary prescriber; “unit preparation” means a preparation (including a mother tincture) that is prepared by a process of solution, extraction or trituration, with a view to being diluted tenfold or one hundredfold (either once or repeatedly) in an inert diluent and then used either in that diluted form or (where applicable) by impregnating tablets, granules, powders or other inert substances.9 (2) In this Order – (a) in Schedules 1 and 2, the following abbreviations are used – “g” for gram; “iu” for international unit of activity; “mcg” for microgram; “mg” for milligram; and “ml” for millilitre; and (b) in Schedule 1 – (i) entries in any of columns 2, 3 and 4 of Parts 1 and 2 relate only to the substances specified in column 1 against which they appear, (ii) where, in relation to a particular substance specified in column 1, an entry in any of columns 2, 3 and 4 bears a number or letter, that entry relates only to entries in the other of columns 2, 3 and 4 that bear the same number or letter, and (iii) the entries in column 4 of Part 1 shall be read subject to the note at the end of that Part. (3) Without prejudice to Article 10 of the Interpretation (Jersey) Law 195410, every provision in the Medicines (Jersey) Law 199511 that relates in any other way to its interpretation shall also apply in the same way to this Order, unless the context otherwise requires.

2 Prescription only medicines The following descriptions and classes of medicinal products are specified for the purposes of Article 57(1)(a) of the Law, and are accordingly prescription only medicines, namely – (a) medicinal products that consist of or contain a substance specified in column 1 of Part 1 of Schedule 1 to this Order;

Revised Edition – 1 January 2019 Page - 7 20.625.95

Article 3 Medicines (Prescription Only) (Jersey) Order 1997

(b) medicinal products that are controlled drugs; (c) medicinal products that are for parenteral administration, whether or not they fall within sub-paragraph (a) or (b) of this paragraph; (d) medicinal products that – (i) are not of a description and do not fall within a class specified in any of sub-paragraphs (a), (b) and (c) of this paragraph, (ii) are of a description in respect of which the conditions in Article 58(1) of the Law are fulfilled, and (iii) are products in respect of which a product licence is granted, after the commencement of this Order, containing a provision to the effect that the method of sale or supply of the medicinal product is to be only in accordance with a prescription given by a person who is an appropriate practitioner; and (e) cyanogenetic substances, other than preparations for external use.12

3 Medicinal products that are not prescription only medicines (1) Notwithstanding Article 2, a medicinal product shall not be a prescription only medicine by reason that it consists of or contains a substance specified in column 1 of Part 1 of Schedule 1, where – (a) in relation to that substance there is an entry in any of columns 2, 3 and 4; (b) the maximum strength in the product of that substance does not exceed the maximum strength (if any) specified in column 2; and (c) the medicinal product is sold or supplied – (i) if a pharmaceutical form or a route of administration is specified in column 3, in such pharmaceutical form, and for administration only by such route, as may be so specified, (ii) if a use is specified in column 3, in a container or package labelled (in either case) to show a use so specified to which the medicinal product is to be put but no use not so specified, (iii) if a maximum dose is specified in column 4, in a container or package labelled (in either case) to show a maximum dose not exceeding that specified, and (iv) if a maximum daily dose is specified in column 4, in a container or package labelled (in either case) to show a maximum daily dose not exceeding that specified. (2) Notwithstanding Article 2 of this Order, a medicinal product shall not be a prescription only medicine by reason that it is a controlled drug, where – (a) it contains not more than one of the substances specified in column 1 of Part 2 of Schedule 1 to this Order and no other controlled drug; (b) it contains that substance at a strength that does not exceed the maximum strength specified in column 2; and

Page - 8 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Article 4

(c) it is sold or supplied – (i) in such pharmaceutical form as may be specified in column 3, and (ii) in or from a container or package labelled (in either case) to show a maximum dose not exceeding that specified in column 4. (4) Notwithstanding Article 2, a medicinal product specified in Part 3 or 4 of Schedule 1 shall not be a prescription only medicine.

4 New medicinal products For the purposes of Article 58(2)(a) of the Law their duration shall be a period of 5 years.

5 Appropriate practitioner13 For the purposes of the Law, the following shall be appropriate practitioners – (a) a doctor; (b) a dentist; (c) a veterinary surgeon; (d) a midwife prescribing practitioner registered under the Health Care (Registration) (Jersey) Law 199514; (e) a nurse prescribing practitioner registered under the Health Care (Registration) (Jersey) Law 1995; (f) a specialist community public health nurse prescribing practitioner registered under the Health Care (Registration) (Jersey) Law 1995.

6 Conditions for prescriptions relating to sale and supply15 (1) For the purposes of Article 57(2)(a) of the Law (read with paragraph (4) of that Article), a prescription only medicine shall not be taken to be sold or supplied in accordance with a prescription given by an appropriate practitioner unless the conditions in paragraph (2) of this Article are fulfilled. (2) The conditions to which paragraph (1) refers are – (a) the prescription shall be written in ink or otherwise so as to be indelible, unless it is a health prescription that is not for a controlled drug specified in any of Schedules 1, 2 and 3 to the Misuse of Drugs (General Provisions) (Jersey) Order 198916, in which case it may be written using carbon paper or similar material; (b) the prescription shall be signed in ink, with his or her own name, by the practitioner giving it; (c) the prescription shall contain the following information –

Revised Edition – 1 January 2019 Page - 9 20.625.95

Article 6 Medicines (Prescription Only) (Jersey) Order 1997

(i) the address of the practitioner giving it, (ii) the appropriate date, (iii) by virtue of which of the paragraphs of Article 5 the practitioner giving it is an appropriate practitioner, (iv) where the practitioner giving it is an appropriate practitioner other than a veterinary surgeon, the name and address of the person for whose treatment it is given and (if that person is under 12) his or her age, and (v) where the practitioner giving it is a veterinary surgeon, the name and address of the person to whom the prescription only medicine is to be delivered, and a declaration by that veterinary surgeon that the prescription only medicine is prescribed for an animal or herd under his or her care; (ca) in the case of a prescription given by a supplementary prescriber, the supplementary prescriber – (i) has given the prescription in accordance with the terms of a clinical management plan containing the information specified in Schedule 4, such plan relating to an individual patient and to which the following are parties – (A) the patient, (B) the patient’s doctor or dentist, and (C) the supplementary prescriber, and (ii) has access to the health records of the patient to whom the clinical management plan relates to the extent that such records are used by the doctor or dentist who is a party to the plan; (d) the prescription shall not be dispensed after the end of the period of 6 months from the appropriate date unless it is a repeatable prescription, in which case it shall not be dispensed for the first time after the end of that period or otherwise than in accordance with the direction contained in the repeatable prescription; and (e) in the case of a repeatable prescription that does not specify the number of times that it may be dispensed, the prescription shall not be dispensed on more than 2 occasions unless it is a prescription for oral contraceptives, in which case it may be dispensed 6 times before the end of the period of 6 months from the appropriate date.17 (3) The restrictions in Article 57(2)(a) of the Law shall not apply to a sale or supply of a prescription only medicine that, by reason only that a condition in paragraph (2) of this Article is not fulfilled, is not in accordance with a prescription given by an appropriate practitioner, where the person selling or supplying the prescription only medicine, having exercised all due diligence, believes on reasonable grounds that that condition is fulfilled in relation to that sale or supply. (4) In paragraph (2), the “appropriate date” means – (a) in the case of a health prescription –

Page - 10 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Article 6A

(i) the date on which it was signed by the practitioner by whom it was given, or (ii) if it also contains a date indicated by him or her as being the date before which it shall not be dispensed, the later of the 2 dates; and (b) in every other case, the date on which the prescription was signed by the practitioner by whom it was given.

6A Conditions for prescriptions – administration18 (1) For the purposes of Article 57(2)(b) of the Law (read with paragraph (4) of that Article), a prescription only medicine shall not be taken to be administered by a supplementary prescriber or by a person acting in accordance with the directions of a supplementary prescriber unless the conditions in paragraph (2) are met. (2) Those conditions are that – (a) the supplementary prescriber is acting in accordance with the terms of a clinical management plan containing the information specified in Schedule 4, such plan relating to an individual patient to which the following are parties – (i) the patient, (ii) the patient’s doctor or dentist, and (iii) the supplementary prescriber; and (b) the supplementary prescriber has access to the health records of the patient to whom the clinical management plan relates to the extent that such records are used by the doctor or dentist who is a party to the plan.

7 Exemption for highly diluted medicinal products The restrictions in Article 57(2) of the Law shall not apply to the sale, supply or administration of a medicinal product that is not for parenteral administration and only consists of or only contains one or more of the substances specified in column 1 of Part 1 or 2 of Schedule 1 to this Order, where – (a) each unit preparation has been diluted to at least one part in a million (6x), and the person selling, supplying or administering the medicinal product has been requested by or on behalf of a particular person and in that person’s presence to use his or her own judgment as to the treatment required; or (b) each such unit preparation has been diluted to at least one part in a million million (6c).

8 Exemptions for specified categories of persons (1) The restrictions in Article 57(2)(a) of the Law shall not apply –

Revised Edition – 1 January 2019 Page - 11 20.625.95

Article 9 Medicines (Prescription Only) (Jersey) Order 1997

(a) to the sale or supply by a person specified in column 1 of Part 1 of Schedule 2 to this Order; or (b) to the supply by a person specified in column 1 of Part 2 of Schedule 2 to this Order, of a prescription only medicine specified in column 2 of Part 1 or 2 of that Schedule in relation to that person, where the conditions in the corresponding paragraph in column 3 of that Part are fulfilled. (2) The restriction in Article 57(2)(b) of the Law shall not apply to the administration by a person specified in column 1 of Part 3 of Schedule 2 to this Order of a prescription only medicine for parenteral administration specified in column 2 of that Part in relation to that person, where the conditions in the corresponding paragraph in column 3 of that Part are fulfilled.

9 Exemption for emergency sale or supply (1) The restrictions in Article 57(2)(a) of the Law shall not apply to the sale or supply of a prescription only medicine by a person who is lawfully conducting a retail pharmacy business, where the conditions in paragraph (2) of this Article or the alternative conditions in paragraph (3) of this Article are fulfilled. (2) The conditions to which paragraph (1) of this Article refers are – (a) the pharmacist by or under whose supervision the prescription only medicine is to be sold or supplied is satisfied that the sale or supply has been requested by a doctor who, by reason of any emergency, is unable to furnish a prescription immediately; (b) the doctor has undertaken to furnish the person lawfully conducting the retail pharmacy business with a prescription within 72 hours; (c) the prescription only medicine is sold or supplied in accordance with the directions of the doctor requesting it; (d) the prescription only medicine is not a controlled drug specified in any of Schedules 1, 2 and 3 to the Misuse of Drugs (General Provisions) (Jersey) Order 1989;19 and (e) an entry is made in the register to be kept under Article 3(1) of the Medicines (Sale and Supply) (Miscellaneous Provisions) (Jersey) Order 199720, within the appropriate time specified in that Article, of the information in paragraph 1 of Schedule 2 to that Order. (3) The alternative conditions to which paragraph (1) of this Article refers are – (a) the pharmacist by or under whose supervision the prescription only medicine is to be sold or supplied has interviewed the person requesting a prescription only medicine and is satisfied – (i) that there is an immediate need for that prescription only medicine to be sold or supplied and that it is impracticable in the circumstances to obtain a prescription without undue delay,

Page - 12 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Article 9

(ii) that treatment with that prescription only medicine has been prescribed on a previous occasion by a doctor for the person requesting it from the pharmacist, or (as far as the pharmacist is reasonably able to ascertain) has been lawfully prescribed on a previous occasion by a medical practitioner outside Jersey for the person requesting it from the pharmacist, and (iii) as to the dose which, in the circumstances, it would be appropriate for that person to take; (b) the prescription only medicine – (i) will be sold or supplied in no greater quantity than will provide 5 days’ treatment, (ii) is a preparation of insulin, an aerosol for the relief of asthma, an ointment or a cream, and has been made up for sale in a container elsewhere than at the place of sale or supply, and is the smallest pack that the pharmacist has available for sale or supply, (iii) is an oral contraceptive and is sufficient, but no more than sufficient, for a full cycle, or (iv) is an antibiotic for oral administration in liquid form, and is the smallest quantity that will provide a full course of treatment; (c) the prescription only medicine does not consist of or contain a substance specified in Schedule 3 to this Order and is not a controlled drug specified in any of the Schedules to the Misuse of Drugs (General Provisions) (Jersey) Order 198921; (d) an entry is made in the register to be kept under Article 3(1) of the Medicines (Sale and Supply) (Miscellaneous Provisions) (Jersey) Order 199722 within the appropriate time specified in that Article, of the information in paragraph 3 of Schedule 2 to that Order; and (e) the container or package of the prescription only medicine is labelled so as to show – (i) the date on which the prescription only medicine is sold or supplied, (ii) the name, quantity and (unless it is apparent from the name) the pharmaceutical form and strength of the prescription only medicine, (iii) the name of the person requesting the prescription only medicine, (iv) the name and address of the registered pharmacy from which the prescription only medicine is sold or supplied, and (v) the words “Emergency Supply”.23 (4) The conditions in paragraph (2)(d) of this Article and in paragraph (3)(c) of this Article shall not apply where the prescription only medicine – (a) consists of or contains phenobarbitone or phenobarbitone sodium (but no other substance specified in Schedule 3 to this Order or in

Revised Edition – 1 January 2019 Page - 13 20.625.95

Article 10 Medicines (Prescription Only) (Jersey) Order 1997

any of the Schedules to the Misuse of Drugs (General Provisions) (Jersey) Order 198924); and (b) is sold or supplied for use in the treatment of epilepsy.

10 Exemption for sale or supply in hospitals or the prison25 (1) The restrictions in Article 57(2)(a) of the Law shall not apply to the sale or supply of any prescription only medicine – (a) in the course of the business of a hospital; or (b) by a pharmacy to the prison under the terms of a contract to supply medicinal products for the benefit of prisoners, in accordance with the written directions of an appropriate practitioner, other than a supplementary prescriber, even though those directions do not fulfil the conditions in Article 6(2) of this Order. (2) In the case of directions given by a supplementary prescriber, paragraph (1) applies except that the condition in Article 6(2)(ca) must be fulfilled as if the references to a prescription in that sub-paragraph were references to the directions given by the supplementary prescriber.

11 Exemption for authorised needle supply services26 The restrictions of Article 57(2)(a) of the Law shall not apply to the supply by a person, for parenteral administration, of ampoules of sterile water, if the supply is made by the person in the course of acting on behalf of a service provided by or on behalf of the States for the purpose of enabling the supply of syringes, and associated articles, so as to reduce the spread of disease.

12 Exemption for sale or supply in cases involving another’s default The restrictions in Article 57(2)(a) of the Law shall not apply to the sale or supply of a prescription only medicine by a person who, having exercised all due diligence, believes on reasonable grounds that the product sold or supplied is not a prescription only medicine, and it is because of an act or default of another person that the product is a product to which that sub-paragraph applies.

13 Exemption in the case of forged prescription The restrictions in Article 57(2)(a) of the Law shall not apply to the sale or supply of a prescription only medicine by a pharmacist in accordance with a forged prescription where the pharmacist, having exercised all due diligence, believes on reasonable grounds that the prescription is genuine.

14 Exemption for parenteral administration to human beings The restriction in Article 57(2)(b) of the Law shall not apply to the administration to human beings of any of the following medicinal products for parenteral administration, namely – adrenaline injection BP;

Page - 14 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Article 15

sulphate injection; chlorpheniramine injection; cobalt edetate injection; dextrose injection strong B.P.C.; injection; glucagon injection; injection; injection; naloxone injection; hydrochloride injection; snake venom antiserum; sodium nitrite injection; sodium thiosulphate injection; and sterile pralidoxime injection, where it is administered for the purpose of saving life in an emergency.

15 Exemption for non-parenteral administration to human beings The restriction in Article 57(2)(b) of the Law shall not apply to the administration to human beings of a prescription only medicine that is not for parenteral administration.

16 Citation This Order may be cited as the Medicines (Prescription Only) (Jersey) Order 1997.

Revised Edition – 1 January 2019 Page - 15 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

SCHEDULE 1

(Articles 1(2), 2(a), 3(1) and 7)

PART 127

PRESCRIPTION ONLY MEDICINES

[Note – (x) indicates that the entry is to be read subject to paragraph 1 of the note at the end of Part 1 of Schedule 1 (y) indicates that the entry is to be read subject to paragraph 2 of the note at the end of Part 1 of Schedule 1]

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Column 1 Column 2 Column 3 Column 4 Substance Maximum strength Use, Maximum pharmaceutical dose and form or route of maximum administration daily dose Acamprosate Acarbose Acebutolol Hydrochloride Aceclofenac Acemetacin Acetarsol Acetazolamide Acetazolamide Sodium Acetohexamide Chloride 0.2% External Aciclovir Acipimox Acitretin Aclarubicin Hydrochloride Aconite 1.3% External Acrivastine Acrosoxacin Actinomycin C Actinomycin D Adapalene Adenosine Adrenaline (1) By inhaler (2) External

Page - 16 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Adrenaline Acid Tartrate (1) By inhaler (2) External Adrenaline Hydrochloride (1) By inhaler (2) External Adrenocortical Extract Aclofenac Albendazole Dipropionate Alcuronium Chloride Aldesleukin Alendronate Sodium Alfacalcidol Alfuzosin Hydrochloride Allergen Extracts Allopurinol Allyloestrenol Aloxiprin Alphadolone Alphaxalone Alprenolol Alprenolol Hydrochloride Alprostadil Alseroxylon Altretamine Hydrochloride Ambenonium Chloride Ametazole Hydrochloride Amethocaine Any use (except local ophthalmic use) Amethocaine Gentisate Any use (except local ophthalmic use) Amethocaine Any use (except Hydrochloride local ophthalmic use) Amikacin Sulphate Amiloride Hydrochloride Aminocaproic Acid Aminopterin Sodium

Revised Edition – 1 January 2019 Page - 17 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Amiodarone Hydrochloride Amiphenazole Hydrochloride Amisulpride Amitriptyline Embonate Amitriptyline Hydrochloride Amlodipine Besylate Ammonium Bromide Amodiaquine Hydrochloride Amorolfine Hydrochloride Amoxycillin Amoxycillin Sodium Amoxycillin Trihydrate Amphomycin Amphotericin Ampicillin Ampicillin Sodium Ampicillin Trihydrate Amsacrine Amygdalin Amyl Nitrite Amylocaine Any use (except Hydrochloride local ophthalmic use) Anastrazole Ancrod Angiotensin Amide Anistreplase Anterior Pituitary Extract Antimony Barium Tartrate Antimony Dimercaptosuccinate Antimony Thiomalate Antimony Pentasulphide Antimony Potassium Tartrate Antimony Sodium Tartrate Antimony Sodium Thiogycollate

Page - 18 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Antimony Sulphate Antimony Trichloride Antimony Trioxide Antimony Trisulphide Apiol Apomorphine Hydrochloride Apraclonidine Hydrochloride Aprotinin Hydrobromide Argipressin Aristolochia Aristolochia Clematitis Aristolochia Contorta Aristolochia Debelis Aristolochia Fang-chi Aristolochia Manshuriensis Aristolochia Serpentaria Arsenic Arsenic Triiodide Arsenic Trioxide Arsphenamine Aspirin Any form (except non-effervescent tablets or capsules) Atenolol Atorvastatin Atorvastatin Calcium Atovaquone Atracurium Besylate Atropine (1) Internal: (a) by inhaler (b) 300 mcg (b) otherwise (MD) 1 mg than by inhaler (MDD)(x) (2) External (except local ophthalmic use) Atropine Methobromide (1) Internal: (a) by inhaler (b) 400 mcg (b) otherwise (MD) 1.3mg than by inhaler (MDD)(x)

Revised Edition – 1 January 2019 Page - 19 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines (2) External (except local ophthalmic use) Atropine Methonitrate Internal: (a) by inhaler (b) 400 mcg (b) otherwise (MD) 1.3 mg than by inhaler (MDD)(x) Atropine Oxide (1) Internal: Hydrochloride (a) by inhaler (b) 360mcg (b) otherwise (MD) 1.2mg than by inhaler (MDD)(x) (2) External (except local opthalmic use) Atropine Sulphate (1) Internal: (a) by inhaler (b) 360 mcg (b) otherwise (MD) 1.2 mg than by inhaler (MD)(x) (2) External (except local ophthalmic use) Auranofin Azapropazone Azathioprine Azathioprine Sodium Azelastine Hydrochloride Azidocillin Potassium Azithromycin Azlocillin Sodium Aztreonam Bacampicillin Hydrochloride Bacitracin Bacitracin Methylene Disalicylate Bacitracin Baclofen Balsalazide Sodium Bambuterol Hydrochloride Barium Carbonate Barium Chloride Barium Sulphide Beclamide Beclomethasone Beclomethasone Diproprionate

Page - 20 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Belladonna Herb (1) Internal (1) 1 mg of the (2) External alkaloids (MDD) Belladonna Root (1) Internal (1) 1 mg of the (2) External alkaloids (MDD) Bemegride Bemegride Sodium Benapryzine Hydrochloride Bendrofluazide Benethamine Penicillin Benoxaprofen Benperidol Benserazide Hydrochloride Bentiromide Benzathine Penicillin Benzbromarone Benzhexol Hydrochloride Benzilonium Bromide Benzocaine Any use (except local ophthalmic use) Benzoctamine Hydrochloride Benzoyl Peroxide 10.0% External N-Benzoyl Sulphanilamide Benzquinamide Benzquinamide Hydrochloride Benzthiazide Benztropine Mesylate Benzylpenicillin Calcium Benzylpenicillin Potassium Benzylpenicillin Sodium Beractant Betahistine Hydrochloride Betamethasone Adamantoate Betamethasone Dipropionate

Revised Edition – 1 January 2019 Page - 21 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Betamethasone Sodium Phosphate Betaxolol Hydrochloride Chloride Bethanidine Sulphate Bezafibrate Hydrochloride Biperiden Lactate Bismuth Glycollylarsanilate Bisoprolol Fumarate Bleomycin Bleomycin Sulphate Bretylium Tosylate Tartrate Hydrochloride Mesylate Bromperidol Bromvaletone Brotizolam Bufexamac Bumetanide Buphenine Hydrochloride 6 mg (MD) 18 mg (MDD) Bupivacaine Any use (except local ophthalmic use) Bupivacaine Any use (except Hydrochloride local ophthalmic use) Buserelin Acetate Buspirone Hydrochloride Busulphan Butacaine Sulphate Any use (except local ophthalmic use) Butorphenol Tartrate Hydrochloride Calcipotriol Calcipotriol Hydrate Calcitonin Calcitriol

Page - 22 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Calcium Amphomycin Calcium Benzamidosalicylate Calcium Bromide Calcium Bromidolactobionate Calcium Carbimide Calcium Folinate Calcium Metrizoate Calcium Sulphaloxate Candesartan Cilexetil Candicidin Cantharidin 0.01% External Capreomycin Sulphate Captopril Carbamazepine Carbaryl Carbasalate Calcium Carbenicillin Sodium Sodium (1) Pellet (1) 5 mg (MD) 25 mg (MDD)

(2) 2.0% (2) Gel Carbimazole Carbon Tetrachloride Carboplatin Carboprost Trometamol Carbuterol Hydrochloride Carfecillin Sodium Carindacillin Sodium Carisoprodol Carmustine Carperidine Carteolol Hydrochloride Cefaclor Cefadroxil Cefazedone Sodium Cefdinir Cefixime Cefodizime Sodium Cefotaxime Sodium Cefoxitin Sodium Cefpodoxime Proxetil

Revised Edition – 1 January 2019 Page - 23 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Cefprozil Cefsulodin Sodium Ceftazidime Ceftizoxime Sodium Ceftriaxone Sodium Cefuroxime Axetil Cefuroxime Sodium Celiprolol Hydrochloride Cephalexin Cephalexin Sodium Cephaloridine Cephalothin Sodium Cephamandole Nafate Cephazolin Sodium Cephradine Cerium Oxalate Cerivastatin Cerivastatin Sodium Ceruletide Diethylamine Cetirizine Chenodeoxycholic Acid Chloral Hydrate External Chlorambucil Chloramphenicol Chloramphenicol Cinnamate Chloramphenicol Palmitate Chloramphenicol Sodium Succinate Chlorhexadol Acetate Chlormerodrin Chlormethiazole Chlormethiazole Edisylate Chlormezanone (1) 5.0% (1) Internal (2) External Chloroquine Phosphate Prophylaxis of malaria Chloroquine Sulphate Prophylaxis of malaria Chlorothiazide Chlorotrianisene Hydrochloride

Page - 24 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Chlorpromazine Embonate Chlorpromazine Hydrochloride Chlorpropamide Chlorprothixene Hydrochloride Chlortetracycline Chlortetracycline Calcium Chlortetracycline Hydrochloride Chlorthalidone Chlorzoxazone Cholestyramine Chorionic Gonadotrophin Ciclacillin Ciclobendazole Cidofovir Cilastatin Sodium Cilazapril Cimetidine Hydrochloride Cinchocaine 3.0% Any use (except local ophthalmic use) Cinchocaine Equivalent of 3.0% of Any use (except Hydrochloride Cinchocaine local ophthalmic use) Cinchophen Cinoxacin Ciprofibrate Ciprofloxacin Ciprofloxacin Hydrochloride Cisplatin Citalopram Hydrobromide Clarithromycin Clavulanic Acid Clenbuterol Hydrochloride Clindamycin

Revised Edition – 1 January 2019 Page - 25 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Clindamycin Hydrochloride Clindamycin Palmitate Hydrochloride Clindamycin Phosphate Clioquinol (1) 35 mg (1) Treatment of (1) 350 mg mouth ulcers (MDD) (2) External (except treatment of mouth ulcers) Propionate Butyrate Clofazimine Clofibrate Clomiphene Citrate Clomipramine Hydrochloride Clomocycline Clomocycline Sodium Clonidine Clonidine Hydrochloride Clopamide Decanoate Clopenthixol Hydrochloride Clorexolone Acetate External but, in the case of vaginal use, only for the treatment of vaginal candidiasis Cloxacillin Benzathine Cloxacillin Sodium Cocculus Indicus Co-dergocrine Mesylate Colaspase Colchicine Colestipol Hydrochloride Colfosceril Palmitate Colistin Sulphate Colistin Sulphomethate Colistin Sulphomethate Sodium Coniine Conium Leaf 7.0% External

Page - 26 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Corticotrophin Co-tetroxazine Co-Trimoxazole Copropamide Crotethamide Croton Oil Croton Seed Curare Cyclofenil Cyclopenthiazide Hydrochloride Cycloserine Cyclosporin Cyclothiazide Acetate Cytarabine Cytarabine Hydrochloride Dacarbazine Dalteparin Sodium Danthron Dantrolene Sodium Dapsone Dapsone Ethane Ortho Sulphonate Daunorubicin Hydrochloride Deanol Bitartrate 26 mg (MDD) Debrisoquine Sulphate Demecarium Bromide Demeclocycline Demeclocycline Calcium Demeclocycline Hydrochloride Deoxycortone Acetate Deoxycortone Pivalate Deptotropine Citrate Dequalinium Chloride (1) 0.25 mg (1) Internal: throat lozenges or throat pastilles (2) 1.0% (2) External: paint Deserpidine

Revised Edition – 1 January 2019 Page - 27 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Desferrioxamine Mesylate Desflurane Desfluorotriamcinolone Hydrochloride Deslanoside Desmopressin Desoxymethasone Dexamethasone Isonicotinate Dexamethasone Phenylpropionate Dexamethaone Pivalate Dexamethasone Sodium m-Sulphobenzoate Dexamethasone Sodium Phosphate Dexamethasone Troxundate Dexfenfluramine Hydrochloride Internal In the case of Hydrobromide a controlled release preparation: equivalent of 30 mg of Dextromethor- phan (MD) equivalent of 75 mg of Dextromethor- phan (MDD) In any other case: equivalent of 15 mg of Dextromethor- phan (MD) equivalent of 75 mg of Dextromethor- phan (MDD) Dextrothyroxine Sodium

Page - 28 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Diazoxide Hydrochloride Dichloralphenazone Dichlorphenamide Diclofenac Diethylammonium Diclofenac Potassium Diclofenac Sodium Dicyclomine 10 mg (MD) Hydrochloride 60 mg (MDD) Didanosine Dienoestrol Diethanolamine Fusidate Valerate Diflunisal Digitalin Digitalis Leaf Digitalis, Prepared Digitoxin Digoxin Dihydralazine Sulphate Dihydroergotamine Mesylate Dihydrostreptomycin Dihydrostreptomycin Sulphate Diloxanide Furoate Diltiazem Hydrochloride Dimercaprol Dimethisoquin Any use (except Hydrochloride local ophthalmic use) Dimethothiazine Mesylate Dimethyl Sulphoxide Dimethyltubocurarine Bromide Dimethyltubocurarine Chloride Dimethyltubocurarine lodide Dinoprost Dinoprost Trometamol Dinoprostone

Revised Edition – 1 January 2019 Page - 29 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Diphenhydramine All preparations Hydrochloride except liquid- filled capsules Dipivefrin Hydrochloride Dipyridamole Disodium Etidronate Disopyramide Disopyramide Phosphate Distigmine Bromide Disulfiram Dithranol 1.00% Dobutamine Hydrochloride Dolasetron Mesilate Domperidone Maleate Donepezil Donepezil Hydrochloride Hydrochloride Dopexamine Hydrochloride Dorzolamide Hydrochloride Dothiepin Dothiepin Hydrochloride Doxapram Hydrochloride Doxazosin Mesylate Hydrochloride Doxorubicin Doxorubicin Hydrochloride Doxycycline Doxycycline Calcium Chelate Doxycycline Hydrochloride Dyflos Econazole External, but in the case of vaginal use, only for the treatment of vaginal candidiasis

Page - 30 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Econazole Nitrate External, but in the case of vaginal use, only for the treatment of vaginal candidiasis Ecothiopate Iodide Edrophonium Chloride Hydrochloride Eformoterol Fumarate Embutramide Emetine 1.0% Emetine Bismuth Iodide Emetine Hydrochloride Equivalent of 1.0% of Emetine Enalapril Maleate Encephalitis Virus, Tick- borne, Central European Enoxacin Enoxaparin Sodium Enoximone (1) Internal (other (1) 30 mg than nasal sprays (MD) 60 mg or nasal drops) (MDD) (2) 2.0% (2) Nasal sprays or nasal drops (3) External Ephedrine Hydrochloride (1) Internal (other (1) Equivalent than nasal sprays of 30 mg of or nasal drops) Ephedrine (MD) Equivalent of 60 mg of Ephedrine (MDD) (2) Equivalent of (2) Nasal sprays 2.0% of Ephedrine or nasal drops (3) External

Revised Edition – 1 January 2019 Page - 31 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Ephedrine Sulphate (1) Internal (other (1) Equivalent than nasal sprays of 30 mg of or nasal drops) Ephedrine (MD) Equivalent of 60 mg of Ephedrine (MDD) (2) Equivalent of (2) Nasal sprays 2.0% of Ephedrine or nasal drops (3) External Epicillin Epirubicin Epirubicin Hydrochloride Epithiazide Epoetin Alfa Epoetin Beta Epoprostenol Sodium Maleate Ergometrine Tartrate Ergot, Prepared Ergotamine Tartrate Erythromycin Erythromycin Estolate Erythromycin Ethyl Carbonate Erythromycin Ethyl Succinate Erythromycin Lactobionate Erythromycin Phosphate Erythromycin Stearate Erythromycin Thiocyanate Esmolol Hydrochloride Phosphate Estramustine Sodium Phosphate Etafedrine Hydrochloride Ethacrynic Acid Ethambutol Hydrochloride Ethamivan Ethamsylate Ethiazide Ethinyl Ethinyloestradiol Ethionamide

Page - 32 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Ethoglucid Ethoheptazine Citrate Ethopropazine Hydrochloride Ethosuximide Ethotoin Ethyl Biscoumacetate Ethyloestrenol Ethynodiol Diacetate Etodolac Etomidate Etomidate Hydrochloride Etoposide Etretinate Famotidine Fazadinium Bromide Felbinac Felodipine Felypressin Fenbufen Fencamfamin Hydrochloride Fenclofenac Hydrochloride Fenofibrate Fenoprofen Fenoprofen Calcium Fenoterol Hydrobromide Fenticonazole Nitrate External use (but, in the case of vaginal use, only for the treatment of vulvovaginal candidiasis) Feprazone Ferrous Arsenate Ferumoxsil Fexofenadine Hydrochloride Filgrastim Hydrochloride Flecainide Acetate Flosequinan

Revised Edition – 1 January 2019 Page - 33 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Flubendazole Acetonide Flucloxacillin Flucloxacillin Sodium Fluconazole Flucylosine Acetate Flufenamic Acid Flumazenil Flumethasone Flumethasone Pivalate Acetonide Butyl Fluocortolone Hexanoate Fluocortolone Pivalate Fluorescein Dilaurate Fluorouracil Fluorouracil Trometamol Fluoxetine Hydrochloride Flupenthixol Decanoate Flupenthixol Hydrochloride Acetate Fluphenazine Decanoate Fluphenazine Enantate Fluphenazine Hydrochloride Acetate Fluprostenol Sodium Flurandrenolone Flurbiprofen 8.75 mg throat lozenges 43.75 mg (MDD) Flurbiprofen Sodium Propionate Aqueous nasal sprays for the treatment of allergic in persons not less than 18 years Flutrimazole

Page - 34 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Fluvastatin Sodium Fluvoxamine Maleate Folic Acid 500 mcg (MDD) Formoterol Fumarate Foscarnet Sodium Fosfestrol Sodium Fosfomycin Trometamol Fosinopril Sodium Framycetin Sulphate Frusemide Furazolidone Fusafungine Fusidic Acid Gabapentin Gadolinium Gadoteridol Gallamine Triethiodide Ganciclovir Ganciclovir Sodium Gelsemine 0.1% Gelsemium 25 mg (MD) 75 mg (MDD) Gemeprost Gemfibrozil Gentamicin Gentamicin Sulphate Gestronol Hexanoate Glibenclamide Glibornuride Gliclazide Glimepiride Glipizide Gliquidone Glisoxepide Glucagon 1 mg (MD) 2 mg (MDD) Glymidine Gonadorelin Goserelin Acetate Gramicidin 0.2% External

Revised Edition – 1 January 2019 Page - 35 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Granisetron Hydrochloride Griseofulvin Growth Hormone Guanethidine Monosulphate Guanfacine Hydrochloride Guanoclor Sulphate Guanoxan Sulphate Halofantrine Hydrochloride Haloperidol Decanoate Heparin External Heparin Calcium External Hexachlorophane External: (a) 2.0% (a) soaps (b) 0.1% (b) aerosols (c) 0.75% (c) preparations other than soaps and aerosols Hexamine Phenylcinchoninate Hexobarbitone Hexobarbitone Sodium Hexoestrol Hexoestrol Dipropionate L-Histidine Dietary or Hydrochloride nutritive use (1) Internal (1) 0.15 mg (MD) 0.45 mg (MDD) (2) External (except local ophthalmic use) Homatropine 0.2 mg (MD) Hydrobromide 0.6 mg (MDD) Homatropine 2 mg (MD) Methylbromide 6 mg (MDD) Hydralazine Hydrochloride Hydrargaphen Local application to skin Hydrobromic Acid Hydrochlorothiazide Hydrocortisone

Page - 36 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Hydrocortisone Caprylate Hydrocortisone Hydrogen Succinate Hydrocortisone Sodium Phosphate Hydrocortisone Sodium Succinnate Hydrocyanic Acid Hydroflumethiazide Hydroxychloroquine Prophylaxis of Sulphate malaria Hydroxyprogesterone Hydroxyprogesterone Enanthate Hydroxyprogesterone Hexanoate Hydroxyurea Hydroxyzine Embonate Hydroxyzine Hydrochloride Hyoscine (1) 0.15% (1) Internal (2) External (except local ophthalmic use) (1) Internal: (MDD) (x) (a) by inhaler (2) External Hyoscine Hydrobromide (1) Internal: (a) by inhaler (b) otherwise (b) 300 mcg than by inhaler (MD) 900 mcg (MDD)(x) (2) External (except local ophthalmic use) Hyoscine Methobromide (1) Internal: (a) by inhaler (b) otherwise (b) 2.5 mg than by inhaler (MD) 7.5 mg (MDD)(x) (2) External Hyoscine Methonitrate (1) Internal: (a) by inhaler (b) otherwise (b) 2.5 mg than by inhaler (MD) 7.5 mg (MDD)(x)

Revised Edition – 1 January 2019 Page - 37 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines (2) External (1) Internal: (a) by inhaler (b) otherwise (b) 300 mcg than by inhaler (MD) 1 mg (MDD)(x) (2) External

(3) Preparations for the relief of asthma in the form of cigarettes, smoking mixtures or fumigants which contain Hyoscyamine as an alkaloid of Stramonium Hyoscyamine (1) Internal: Hydrobromide (a) by inhaler

(b) otherwise (b) Equiva- than by inhaler lent of 300 mcg of Hyoscyamine (MD) Equi- valent of 1 mg of Hyos- cyamine (MDD)(x) (2) External Hyoscyamine Sulphate (1) Internal: (a) by inhaler (b) otherwise (b) Equiva- than by inhaler lent of 300 mcg of Hyoscyamine (MD) Equivalent of 1 mg of Hyoscyamine (MDD)(x) (2) External Ibuprofen

Page - 38 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Ibuprofen Lysine Rheumatic and muscular pain, pain of non- serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza Internal (a) In the case of a prolonged release preparation 600 mg (MD) 1,200 mg (MDD) (b) In any other case 400 mg (MD) 1,200 mg (MDD) Idarubicin Hydrochloride Idoxuridine Ignatius Bean Imidapril Hydrochloride Imipenem Hydrochloride Imipramine Hydrochloride Imipramine Exchange Resin Bound Salt or Complex Indapamide Hemihydrate Indinavir Indomethacin Indomethacin Sodium Indoramin Hydrochloride Indoprofen Inosine Pranobex Insulin Iodamide

Revised Edition – 1 January 2019 Page - 39 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Iodamide Meglumine Iodamide Sodium Iohexol Iomeprol Iopamidol Iopentol Iothalamic Acid Ioversol Ioxaglic Acid Iprindole Hydrochloride Iproniazid Phosphate Irbesartan Isoaminile Citrate Isocarboxazid Isoconazole Nitrate External, but in the case of vaginal use, only for the treatment of vaginal candidiasis Isoetharine Isoetharine Hydrochloride Isoetharine Mesylate Isoniazid Isoprenaline Hydrochloride Isoprenaline Sulphate Iodide Equivalent of 2.5 mg of Isoprop-amide ion (MD) Equivalent of 5.0 mg of Isoprop-amide ion (MDD) Isradipine Itraconazole Jaborandi External Kanamycin Acid Sulphate Kanamycin Sulphate Hydrochloride Ketoprofen Ketorolac Trometamol Ketotifen Pumarate Labetalol Hydrochloride

Page - 40 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Lachesine Chloride Lacidipine Lamivudine Lamotrigine Lanatoside C Lanatoside Complex A, B and C Lanzoprazole Latamoxef Disodium Latanaprost Lercanidipine Hydrochloride Letrozole Tartrate Levobunolol Hydrochloride Hydrochloride Levocarnitine For dietary supplementation Levodopa Levofloxacin Hemihydrate Lidoflazine Lignocaine Any use (except local ophthalmic use) Lignocaine Any use (except Hydrochloride local ophthalmic use) Lincomycin Lincomycin Hydrochloride Liothyronine Sodium Lisinopril Lithium Carbonate Equivalent of 5 mg of Lithium (MD) Equivalent of 15 mg of Lithium (MDD) Lithium Citrate

Revised Edition – 1 January 2019 Page - 41 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Lithium Sulphate Equivalent of 5 mg of Lithium (MD) Equivalent of 5 mg of Lithium (MDD) Lithium Succinate Lobeline (1) Internal (1) 3 mg (MD) 9 mg (MDD) (2) External Lobeline Hydrochloride (1) Internal (1) Equiva- lent of 3 mg of Lobeline (MD) Equivalent of 9 mg of Lobeline (MDD) (2) External Lobeline Sulphate (1) Internal (1) Equiva- lent of 3 mg of Lobeline (MD) Equivalent of 9 mg of Lobeline (MDD) (2) External Lodaximide Trometamol equivalent of 0.1% For the treatment Lodoxamide of ocular signs and symptoms of allergic conjunctivitis, in adults and in children aged 4 years and over Lofepramine Hydrochloride Lofexidine Hydrochloride Lomefloxacin Hydrochloride Lornoxicam Lomustine Loperamide Treatment of Hydrochloride acute diarrhoea Loratidine Losartan Potassium

Page - 42 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Succinate Surfactant Porcine Luteinising Hormone Lymecycline Lynoestrenol Lypressin Lysuride Maleate Mafenide Mafenide Acetate Mafenide Hydrochloride Mafenide Propionate 5.0% Eye drops Magnesium Fluoride Magnesium Metrizoate Mandragora Autumnalis Mannomustine Hydrochloride Hydrochloride Mebanazine Mebendazole (a) For the (a) 135mg Hydrochloride symptomatic (MD) 405mg relief of irritable (MDD) bowel syndrome (b) For uses other (b) 100 mg than the (MD) 300mg symptomatic (MDD) relief of irritable bowel syndrome Mebeverine Pamoate Mebhydrolin Mebhydrolin Napadisylate Mecamylamine Hydrochloride Mecillinam Hydrochloride Medigoxin Acetate Mefenamic Acid Mefloquine Hydrochloride Mefruside

Revised Edition – 1 January 2019 Page - 43 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Meglumine Gadopentetate Meglumine lodoxamate Meglumine loglycamate Meglumine lothalamate Meglumine lotroxate Meglumine loxaglate Meloxicam Melphalan Melphalan Hydrochloride Menotrophin Bromide 25 mg (MD) 75 mg (MDD) Mephenesin Mephenesin Carbamate Mepivacaine Any use (except Hydrochloride local ophthalmic use) Meptazinol Hydrochloride Mercaptamine Bitartrate Mercaptopurine Mersalyl Mersalyl Acid Mesalazine Mestranol Metaraminol Tartrate Metergoline Metformin Hydrochloride Methacycline Methacycline Calcium Methacycline Hydrochloride Methallenoestril Methandienone Methicillin Sodium Methixene Methixene Hydrochloride Methocarbamol Methocidin Throat lozenges and throat pastilles Methohexitone Sodium Methoin Methoserpidine

Page - 44 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Methotrexate Sodium Methotrimeprazine Methotrimeprazine Hydrochloride Methotrimeprazine Maleate 0.25% Nasal sprays, or Hydrochloride nasal drops, not containing in either case liquid paraffin as a vehicle Methsuximide Methyclothiazide Methyldopa Hydrochloride Methylephedrine 30 mg (MD) Hydrochloride 60 mg (MDD) Methylprednisolone Acetate Methylprednisolone Sodium Succinate Methylthiouracil Maleate Metipranolol Metirosine Hydrochloride Metolazone Metoloprolol Tartrate Metoprolol Fumarate Metoprolol Succinate Metronidazole Metronidazole Benzoate Mexiletine Hydrochloride Mezlocillin Sodium Hydrochloride Mibefradil Dihydrochloride External

Revised Edition – 1 January 2019 Page - 45 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Miconazole Nitrate External, but in the case of vaginal use, only for the treatment of vaginal candidiasis Miglitol Milrinone Milrinone Lactate Minocycline Minocycline Hydrochloride (1) 2.0% External (2) 5.0% External, for the treatment of alopecia androgenetica in men who have attained the age of 18 years but have not attained the age of 65 years Misoprostol Mitobronitol Mitomycin C Mitozantrone Hydrochloride Mivacurium Chloride Mizolastine Moclobemide Modafinil Moexipril Hydrochloride Molgramostim Molindone Hydrochloride Furoate Moracizine Hydrochloride Morazone Hydrochloride Moxisylyte Hydrochloride Moxonidine Mupirocin Calcium Mustine Hydrochloride Mycophenolate Mofetil

Page - 46 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Nabumetone Nadolol Nafarelin Acetate Naftidrofuryl Oxalate Naftifine Hydrochloride Nalbuphine Hydrochloride Nalidixic Acid Hydrobromide Naloxone Hydrochloride Naltrexone Hydrochloride Decanoate Nandrolone Phenylpropionate (1) 0.05% (1) Nasal sprays, Hydrochloride or nasal drops, not containing in either case liquid paraffin as a vehicle (2) 0.015% (2) Eye drops Naphazoline Nitrate 0.05% Nasal sprays, or nasal drops, not containing in either case liquid paraffin as a vehicle Naproxen Naproxen Sodium Naratriptan Hydrochloride Natamycin Nebivolol Hydrochloride Sodium Nefazadone Hydrochloride Hydrochloride Neomycin Neomycin Oleate Neomycin Palmitate Neomycin Sulphate Neomycin Undecanoate Neostigmine Bromide Neostigmine Methylsulphate Netilmicin Sulphate

Revised Edition – 1 January 2019 Page - 47 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Nicardipine Hydrochloride Niceritrol Nicotinic Acid Any use (except 600 mg for the treatment (MDD) of hyperlipid- aemia) Nicoumalone Nifedipine Nifenazone Nikethamide Nimodipine Niridazole Nisoldipine Nitrendipine Nitrofurantoin Nitrofurazone Nizatidine Nomifensine Maleate Noradrenaline Noradrenaline Acid Tartrate Norethisterone Heptanoate Norethynodrel Norfloxacin Hydrochloride Noscapine Hydrochloride Novobiocin Calcium Novobiocin Sodium Nux Vomica Seed Nystatin Octacosactrin Octreotide Oestradiol Oestradiol Benzoate Oestradiol Cypionate Oestradiol Dipropionate Oestradiol Diundecanoate

Page - 48 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Oestradiol Enanthate Oestradiol Phenylpropionate Oestradiol Undecanoate Oestradiol Valerate Oestriol Oestriol Di-Hemi Succinate Oestrogenic Substances, Conjugated Oestrone Ofloxacin Olsalazine Sodium Omeprazole Omeprazole Magnesium Ondansetron Ondansetron Hydrochloride Orciprenaline Sulphate Citrate Orphenadrine Hydrochloride Ouabain Ovarian Gland, Dried Oxamniquine Oxandronolone Oxantel Pamoate Oxaprozin Oxatomide Oxedrine Tartrate Oxethazaine Oxidronate Sodium Oxolinic Acid Oxpentifylline Oxprenolol Any use (except Hydrochloride local ophthalmic use) Oxybuprocaine Hydrochloride Hydrochloride Oxypertine

Revised Edition – 1 January 2019 Page - 49 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Oxypertine Hydrochloride Oxyphenbutazone Hydrochloride 5 mg (MD) 15 mg (MDD) Oxytetracycline Oxytetracycline Calcium Oxytetracycline Dihydrate Oxytetracycline Hydrochloride Oxytocin, Natural Oxytocin, Synthetic Pamidronate Disodium Pancreatin (1) 21,000 European (1) Capsules Pharmacopoeia units of lipase per capsule

(2) 25,000 European (2) Powder Pharmacopoeia units of lipase per g Pancuronium Bromide Pantoprazole Pantoprazole Sodium Papaverine (1) By inhaler (2) Otherwise (2) 50 mg than by inhaler (MD) 150 mg (MDD) Papaverine Hydrochloride (1) By inhaler (2) Otherwise (2) than by inhaler Equivalent of 50 mg of Papaverine (MD) Equivalent of 150 mg of Papaverine (MDD) Paracetamol Any form (except non-effervescent tablets and capsules) Paraldehyde Paramethadione Acetate Parathyroid Gland

Page - 50 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Hydrochloride Hydrochloride Pecilocin Penamecillin Penbutolol Sulphate Penciclovir Penicillinamine Penicillinamine Hydrochloride Pentamidine Isethionate Pentamidronate Disodium 5 mg (MD) Methobromide 15 mg (MDD) Pentolinium Tartrate Perfluamine Mesylate Perhexiline Maleate Perindopril Pericyazine Perindopril Erbumine Perphenazine Phenacetin 0.1% Phenazone External Phenazone and Citrate Phenazone Salicylate Phenbutrazate Hydrochloride Phenelzine Sulphate Phenethicillin Potassium Phenformin Hydrochloride Hydrochloride Phenindione Phenolphthalein Phenoxybenzamine Hydrochloride Phenoxymethylpenicillin Phenoxymethylpenicillin Calcium Phenoxymethylpenicillin Potassium Phenprocoumon Phensuximide Phentolamine Hydrochloride

Revised Edition – 1 January 2019 Page - 51 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Phentolamine Mesylate Phenylbutazone Phenylbutazone Sodium Internal: (a) all (a) 25 mg Hydrochloride preparations (MD) (except 100 mg controlled release (MDD) capsules, nasal sprays or nasal drops) (b) controlled (b) 50 mg release capsules (MD) 100 mg (MDD) (c) 2.0% (c) nasal sprays or nasal drops Phenytoin Phenytoin Sodium Phthalylsulphathiazole Physostigmine Physostigmine Aminoxide Salicylate Physostigmine Salicylate Physostigmine Sulphate Phytomenadine Any use except the prevention or treatment of haemorrhagic disorders Picrotoxin Pilocarpine Hydrochloride Pilocarpine Nitrate Pimozide Pindolol 5 mg (MD) 15 mg (MDD) Piperacillin Sodium Oestrone Sulphate 50 mg (MD) Hydrochloride 150 mg (MDD) Pipothiazine Palmitate Piracetam Pirbuterol Acetate Pirbuterol Hydrochloride

Page - 52 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Dihydrochloride Monohydrate Pirenzepine Hydrochloride Piretamide Piroxicam Piroxicam Beta- Cyclodextrin Pituitary Gland (Whole By inhaler Dried) Pituitary, Powdered By inhaler (Posterior Lobe) Pivampicillin Hydrochloride Pivmecillinam Pivmecillinam Hydrochloride Pizotifen Malate Plicamycin Podophyllotoxin Podophyllum Podophyllum Indian Podophyllum Resin 20.0% External: ointment or impregnated plaster Methylsulphate 2 mg (MDD) 6 mg (MDD) Polidexide Polymyxin B Sulphate Polyestradiol Phosphate Polythiazide Poppy Capsule Potassium Arsenite 0.0127% Potassium Bromide Potassium Clavulanate Potassium Perchlorate Practolol Pralidoxime Chloride Pralidoxime lodide Pralidoxime Mesylate Dihydrochloride

Revised Edition – 1 January 2019 Page - 53 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Pravastatin Sodium Prazosin Hydrochloride Prednisolone Butylacetate Prednisolone Hexanoate Prednisolone Pivalate Prednisolone Sodium Phosphate Prednisolone Sodium m- Sulphobenzoate Prednisolone 21-Steaglate Prednisolone m- Sulphobenzoate Prednisone Acetate Prenalterol Hydrochloride Prenylamine Lactate Prilocaine Hydrochloride Any use (except local ophthalmic use) Primidone Probenecid Probucol Procainamide Hydrochloride Procaine Hydrochloride Any use (except local ophthalmic use) Procaine Penicillin Procarbazine Hydrochloride Prochlorperazine Prochlorperazine Edisylate Prochlorperazine Maleate Prochlorperazine Mesylate Hydrochloride Prolactin Prolintane Hydrochloride Embonate Promazine Hydrochloride Propafenone Propafenone Hydrochloride

Page - 54 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Propanidid 15 mg (MD) 45 mg (MDD) Hydrochloride Propofol Propranolol Hydrochloride Propylthiouracil Proquazone Protamine Sulphate Prothionamide Protirelin Hydrochloride Proxymetacaine Any use (except Hydrochloride local ophthalmic use) Internal In the case of Hydrochloride a controlled release preparation: 120 mg (MD) 180 mg (MDD) In any other case: 60 mg (MD) 180 mg (MDD) Pseudoephedrine 60 mg (MD) Sulphate 180 mg (MDD) Pyrantel Embonate Pyrantel Tartrate Pyrazinamide Pyridostigmine Bromide Pyrimethamine Fumarate Quinagolide Hydrochloride Quinapril Quinapril Hydrochloride Quinestradol Quinestrol Quinethazone

Revised Edition – 1 January 2019 Page - 55 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Quinidine Bisulphate Quinidine Polygalacturonate Quinidine Sulphate Quinine 100 mg (MD) 300 mg (MDD) Quinine Bisulphate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Dihydrochloride Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Ethyl Carbonate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Glycero- Equivalent of phosphate 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Hydrobromide Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Hydrocholride Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD)

Page - 56 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Quinine Iodobismuthate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Equivalent of Phenylcinchoninate 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Phosphate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Salicylate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Sulphate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine Tannate Equivalent of 100 mg of Quinine (MD) Equivalent of 300 mg of Quinine (MDD) Quinine and Hydrochloride Ramipril Ranitidine Bismuth Citrate Ranitidine Hydrochloride

Revised Edition – 1 January 2019 Page - 57 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Rauwolfia Serpentina Rauwolfia Vomitoria Reboxetine Reboxetine Mesilate Remoxipride Hydrochloride Reproterol Hydrochloride Rescinnamine Reserpine Rifabutin Rifampicin Rifampicin Sodium Rifamycin Rimiterol Hydrobromide Ritodrine Hydrochloride Ritonavir Rolitetracycline Nitrate Ropinorole Hydrochloride Sabadilla Salbutamol Salbutamol Sulphate Salcatonin Salcatonin Hydrated Polyacetate Salmefamol Salmeterol Hydroxynaphthoate Salsalate Saquinavir Saralasin Acetate Hydrochloride Sera and Antisera – Botulin Antitoxin Diphtheria Antitoxin Gas-gangrene Antitoxin (Oedematiens) Gas-gangrene Antitoxin (Perfringens) Gas-gangrene Antitoxin (Septicum) Mixed Gas-gangrene Antitoxin Leptospira Antiserum Rabies Antiserum

Page - 58 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Scorpion Venom Antiserum Snake Venom Antiserum Tetanus Antitoxin Serum Gonadotrophin Sermorelin Sertindole Sertraline Hydrochloride Sevoflurane Sibutramine Hydrochloride Silver Sulphadiazine Simvastatin Sissomicin Sissomicin Sulphate Snake Venoms Sodium Acetrizoate Sodium Aminosalicylate Sodium Antimonylgluconate Sodium Arsanilate Sodium Arsenate Sodium Arsenite 0.013% Sodium Bromide Sodium Clodronate Sodium Cromoglycate Administration through the nose Sodium Ethacrynate Sodium Fluoride (1) 0.33% (y) (1) Dentifrices (2) Other preparations for use in the prevention of dental of dental caries in the form of – (a)tablets or (a) 2.2 mg drops; (MDD) (b) 0.2% (b) mouth-washes (other than those for daily use); (c) 0.05% (c) mouth-washes for daily use Sodium Fusidate Sodium Metrizoate Sodium 1.14% (y) Dentifrice Monofluorophosphate Sodium Stibogluconate

Revised Edition – 1 January 2019 Page - 59 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Sodium Somatorelin Acetate Somatrem Somatropin Sotalol Hydrochloride Sparfloxacin Spectinomycin Spectinomycin Hydrocloride Spiramycin Spiramycin Adipate Stannous Fluoride (1) 0.62% (y) (1) Dentifrice (2) 0.4% (2) Dental gels for use in the prevention and treatment of dental caries and decalcification of the teeth Stanolone Stavudine Stilboestrol Stilboestrol Dipropionate Streptodornase External Streptokinase External Streptomycin Streptomycin Sulphate Strychnine Strychnine Arsenate Strychnine Hydrochloride Strychnine Nitrate Styramate Succinylsulphathiazole Sucralfate Sulbactam Sodium Sulbenicillin Sulbenicillin Sodium Sulbenicillin Tosylate Sulconazole Nitrate External (except vaginal use) Sulfacytine Sulfadoxine Sulfamonomethoxine Sulindac Sulphabenzamide

Page - 60 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Sulphacetamide Sulphacetamide Sodium Sulphadiazine Sulphadiazine Sodium Sulphadimethoxine Sulphadimidine Sulphadimidine Sodium Sulphafurazole Sulphafurazole Diethanolamine Sulphaguanidine Sulphaloxic Acid Sulphamerazine Sulphamerazine Sodium Sulphamethizole Sulphamethoxazole Sulphamethoxydazine Sulphamethoxypyridazine Sulphamethoxypyridazine Sodium Sulphametopyrazine Sulphamoxole Sulphanilamide Sulphaphenazole Sulphapyridine Sulphapyridine Sodium Sulphasalazine Sulphathiazole Sulphathiazole Sodium Sulphaurea Sulphinpyrazone Sultamicillin Sultamicillin Tosylate Sulthiame Sumatriptan Sumatriptan Succinate Suprofen Suxamethonium Bromide Suxamethonium Chloride Suxethonium Bromide Tacalcitol Monohydrate Tacrine Hydrochloride Talampicillin Talampicillin Hydrochloride Talampicillin Napsylate

Revised Edition – 1 January 2019 Page - 61 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Tamoxifen Citrate Tamsulosin Hydrochloride Tazarotene Tazobactam Sodium Teicoplanin Temocapril Hydrochloride Temocillin Sodium Tenoxicam Terazosan Hydrochloride Terbinafine Terbinafine Hydrochloride Terbutaline Terbutaline Sulphate Terfenadine Hydrochloride Tertipressin Testosterone 17B Chloral Hemiacetal Testosterone Cyclohexyl- propionate Testosterone Phenylpropionate Tetrabenazine Tetracosactrin Tetracosactrin Acetate Tetracycline Tetracycline Hydrochloride Tetracycline Phosphate Complex Tetroxoprim Thallium Acetate Thallous Chloride Thiabendazole Thiambutosine

Page - 62 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Thiethylperazine Thiethylperazine Maleate Thiocarlide Thioguanine Thiopentone Sodium Hydrochloride Thioproperazine Mesylate Thioridazine Hydrochloride Thiosinamine Thiotepa Thiothixene Thiouracil Thymoxamine Hydrochloride Thyroid Thyrotrophin Thyroxine Sodium Tiamulin Fumarate Tiaprofenic Acid Ticarcillin Sodium Ticlopidine Hydrochloride Hydrobromide Tiludronate Disodium Timolol Maleate Tinidazole Tinzaparin Tioconazole 2.0% (1) External, but in the case of vaginal use only, external use for treatment of vaginal candidiasis Tizanidine Hydrochloride Tobramycin Tobramycin Sulphate Tocainide Hydrochloride Hydrochloride Tolazamide Tolazoline Hydrochloride External Tolbutamide Tolbutamide Sodium

Revised Edition – 1 January 2019 Page - 63 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Tolfenamic Acid Tolmetin Sodium Topiramate Torasemide Toremifene Hydrochloride Trandolapril Tranexamic Acid Tranylepromine Sulphate Trazodone Hydrochloride Treosulfan Tretinoin Triamcinolone Hexacetonide Triamterene Tribavirin Triclofos Sodium Trientine Dihydrochloride Trifluoperazine Trifluoperazine Hydrochloride Trifluperidol Trifluperidol Hydrochloride Trimeprazine Trimeprazine Tartrate Trimetaphan Camsylate Trimetazidine Trimetazidine Hydrochloride Trimethoprim Maleate Trimipramine Mesylate Tropisetron Hydrochloride Troxidone L-Tryptophan (1) Dietary or nutritive use (2) Any external use Tubocurarine Chloride Tulobuterol

Page - 64 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Tulobuterol Hydrochloride Tyrothricin Throat lozenges or throat pastilles Uramustine Urea Stibamine Urethane Uridine-5-Triphosphoric Acid Urofollitrophin Urokinase Ursodeoxychloric Acid Vaccines – Athrax Vaccine (Bacillus) Anthracis) Bacillus Calmette- Guerin Vaccine Bacillus Salmonella Typhi Vaccine Percutaneous Bacillus Calmette- Guerin Vaccine Cholera Vaccine Diphtheria Vaccine Adsorbed Diphtheria Vaccine Diphtheria and Tetanus Vaccine Adsorbed Diphtheria and Tetanus Vaccine Diphtheria, Tetanus and Pertussis Vaccine Adsorbed Diphtheria, Tetanus and Pertussis Vaccine Diphtheria, Tetanus and Poliomyelitis Vaccine Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine Eltor Vaccine Influenza Vaccine Hepatitis B Vaccine Measles Vaccine (Live Attenuated)

Revised Edition – 1 January 2019 Page - 65 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Meningococcal Polysaccharide Vaccine Mumps Vaccine Pertussis Vaccine Plague Vaccine Pneumococcal Vaccine (Bacterial Antigen) Poliomyelitis Vaccine (Inactivated) Poliomyelitis Vaccine (Live Oral) Rabies Vaccine Rubella Vaccine (Live Attenuated) Rubella, Mumps, Measles Vaccine Tetanus Vaccine Adsorbed Tetanus Vaccine Tetanus and Pertussis Vaccine Tuberculin Purified Protein Derivative Old Tuberculin Typhoid Vaccine Typhoid – Paratyphoid A and B Vaccine Typhoid – Paratyphoid A and B and Cholera Vaccine Typhoid – Paratyphoid A and B and Tetanus Vaccine Typhus Vaccine Yellow Fever Vaccine Valaciclovir Valaciclovir Hydrochloride Valproic Acid Valsartan Vancomycin Hydrochloride Vasopressin Injection Vasopressin Tannate Vecuronium Bromide Venlafaxine Venlafaxine Hydrochloride

Page - 66 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Verapamil Hydrochloride Veratrine Veratrum (Green and White) Vidarabine Vigabatrin Viloxazine Hydrochloride Vinblastine Sulphate Vincristine Sulphate Vindesine Sulphate Viomycin Pantothenate Viomycin Sulphate Vitamin A (1) Internal (1) 7500 iu (2250 mcg Retinol equivalent) (MDD) (2) External Vitamin A Acetate (1) Internal (1) Equi- valent to 7500 iu Vitamin A (2250 mcg Retinol equivalent) (MDD) (2) External Vitamin A Palmitate (1) Internal (1) Equi- valent to 7500 iu Vitamin A (2250 mcg Retinol equivalent) (MDD) (2) External Warfarin Warfarin Sodium Xamoterol Fumarate Xipamide Yohimbine Hydrochloride Zalcitabine Zidovudine Zimeldine Hydrochloride Zolmitriptan Zolpidem Zomepirac Sodium Zopiclone Zuclopenthixol Acetate

Revised Edition – 1 January 2019 Page - 67 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

Prescription Only Circumstances In Which Substances Are Not Medicine Prescription Only Medicines Zuclopenthixol Decanoate Zuclopenthixol Hydrochloride Note – 1. In relation to a medicinal product that contains more than one of the substances Atropine, Atropine Methobromide, Atropine Methonitrate, Atropine Oxide Hydrochloride, Atropine Sulphate, Hyoscine, Hyoscine Butylbromide, Hyoscine Hydrobromide, Hyoscine Methobromide, Hyoscine Methonitrate, Hyoscyamine, Hyoscyamine Hydrobromide and Hyoscyamine Sulphate, the maximum daily dose for the purposes of column 4 is 1 mg of the total alkaloids contained in the product that are derived from Belladonna, Hyoscyamus, Stramonium or other solanaceous plant, and there is no maximum dose. 2. In relation to a medicinal product that contains more than one of the substances Sodium Fluoride, Sodium Monofluorophosphate and Stannous Fluoride combined in a dentifrice, the maximum strength of the combination for the purposes of column 2 shall not exceed 0.15% calculated as Fluorine.

Page - 68 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

PART 2

(Articles 1(2), 3(2) and 7)

Controlled Drugs Circumstances In Which Controlled Drugs Are Not Prescription Only Medicines Column 1 Column 2 Column 3 Column 4 Substance Maximum Pharmaceutical Maximum dose strength form ; its salts Equivalent of 1.5% Equivalent of 20 of Codeine mg of Codeine Monohydrate Monohydrate ; its Equivalent of Equivalent of 10 salts 1.5%of mg of Dihydroco- Dihydrocodeine deine ; its Equivalent of 0.2% Equivalent of 7.5 salts of Ethylmorphine mg of Ethyl- morphine Morphine; its salts (1) Equivalent of (1) Liquid (1) Equivalent of 3 0.02% of anhydrous mg of anhydrous Morphine Morphine (2) Equivalent of (2) Solid (2) Equivalent of 3 0.04% of anhydrous mg of anhydrous Morphine; Morphine equivalent of 300 mcg of anhydrous Morphine Medicinal (1) Equivalent of (1) Liquid (1) Equivalent of 3 0.02%of anhydrous mg of anhydrous Morphine Morphine (2) Equivalent of (2) Solid (2) Equivalent of 3 0.04% of anhydrous mg of anhydrous Morphine Morphine ; its salts Equivalent of 1.5% Equivalent of 20 of Pholcodine mg of Pholcodine

Revised Edition – 1 January 2019 Page - 69 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

PART 3

(Article 3(4))

NAMED PRODUCTS THAT ARE NOT PRESCRIPTION ONLY MEDICINES

TABLE A

Name and product licence number of medicinal products that are not prescription only medicines

Adcortyl in Orabase for Mouth Ulcers 0034/0321 Anusol Plus HC Ointment 0018/0223 Anusol Plus HC Suppositories 0018/0224 Beechams Hydrocortisone Cream 0079/0203 Boots Hydrocortisone Ointment 0014/0364 Calacort Cream 12650/0001 Canesten Hydrocortisone Cream 0010/0216 Corlan Pellets 0039/0397 Cortaid Cream 1% 0032/0126 Corteze Cream 0001/0107 Cortiderm 2855/0010 Cortril Topical Ointment 1% (non-greasy) 0057/0251 Dermacort Hydrocortisone Cream 8265/0002 Dioderm Hydrocortisone Cream 0173/0153 Efcortelan Eczema Cream 10949/0234 Efcortelan Eczema Ointment 10949/0235 Eurax HC Cream 0001/5010R Hc45 Hydrocortisone Cream 0327/0039 Herpetad Cold Sore Cream 4986/0007 Jungle Formula Bite & Sting Relief Cream 2855/0010 Lanacort Cream 3157/0008 Lanacort Ointment 3157/0011 Perinal Spray 0173/0049 Pharmacort Cream 0.5% 0011/0077 Proctocream HC 0036/0065 Soothelip Cold Sore Cream 0142/0426 Timocort Hydrocortisone Cream 0044/0090 Timocort Hydrocortisone Cream 1% 0063/0076 Wasp-Eze Hydrocortisone Cream 8452/0012 Zaclovir Cold Sore Cream 4986/0007 Zenoxone Cream 0181/0033 Zovirax Cold Sore Cream 0003/0304

Page - 70 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

TABLE B

Relevant product licence holder and name and product licence number of medicinal products that are not prescription only medicines

Leo Laboratories Limited: Hydrocortisone Acetate Cream BP 0.5% 0043/0150 Hydrocortisone Acetate Cream BP 1.0% 0043/0151 Richard Daniel and Son Limited: Hydrocortisone Cream BP 1.0% 0842/0011

Revised Edition – 1 January 2019 Page - 71 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

PART 428

(Article 3(4))

OTHER MEDICINAL PRODUCTS THAT ARE NOT PRESCRIPTION ONLY MEDICINES

1 A medicinal product shall not be a prescription only medicine by reason that it contains the substance aciclovir, where – (a) the maximum strength of the aciclovir in the medicinal product does not exceed 5%; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 2 g of the medicinal product; and (c) the medicinal product is indicated only for external application for the treatment of herpes simplex virus infections of the lips and face (Herpes labialis). 2 A medicinal product shall not be a prescription only medicine by reason that it contains the substance acrivastine, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 240 mg of acrivastine; and (b) the container or package is labelled to show a maximum daily dose of 24 mg of acrivastine. 3 A medicinal product shall not be a prescription only medicine by reason that it contains the substance aloxiprin, where – (a) the medicinal product is in the form of non-effervescent tablets or capsules; (b) the maximum strength of the medicinal product in each tablet or capsule does not exceed 620 mg; (c) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied in one container or package does not exceed 32; and (d) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied to a person at any one time does not exceed 100. 4 A medicinal product shall not be a prescription only medicine by reason that it contains the substance aloxiprin, where it is not in the form of a non-effervescent tablet or capsule. 5 A medicinal product shall not be a prescription only medicine by reason that it contains the substance aspirin, where – (a) the medicinal product is in the form of non-effervescent tablets or capsules; (b) the maximum strength of the medicinal product in each tablet or capsule does not exceed 75 mg;

Page - 72 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

(c) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied in one container or package does not exceed 100; and (d) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied to a person at any one time does not exceed 100. 6 A medicinal product shall not be a prescription only medicine by reason that it contains the substance aspirin, where – (a) the medicinal product is in the form of non-effervescent tablets or capsules; (b) the maximum strength of the medicinal product in each tablet or capsule does not exceed 325 mg; (c) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied in one container or package does not exceed 32; and (d) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied to a person at any one time does not exceed 100. 7 A medicinal product shall not be a prescription only medicine by reason that it contains the substance azelastine hydrochloride, where – (a) the medicinal product is in non-aerosol, aqueous form for nasal administration; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 36 doses each of which contains not more than 140 mcg of azelastine hydrochloride; (c) the container or package is labelled to show a maximum dose of 140 mcg per nostril and a maximum daily dose of 280 mcg per nostril of azelastine hydrochloride; and (d) the medicinal product is indicated only for the treatment of seasonal or perennial allergic rhinitis, in persons aged not less than 5 years. 8 A medicinal product shall not be a prescription only medicine by reason that it contains the substance azelastine hydrochloride, where – (a) the medicinal product is in the form of eye drops; and (b) it is indicated only for the treatment of allergic conjunctivitis, in persons aged not less than 12 years. 9 A medicinal product shall not be a prescription only medicine by reason that it contains the substance beclomethasone dipropionate, where – (a) the medicinal product is in non-aerosol form for nasal administration; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 5,600mcg of beclomethasone diopropionate;

Revised Edition – 1 January 2019 Page - 73 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

(c) the container or package is labelled to show a maximum dose of 100 mcg per nostril and a maximum daily dose of 200 mcg per nostril of beclomethasone dipropionate; and (d) the medicinal product is indicated only for the prevention of treatment of allergic rhinitis, in persons aged not less than 12 years. 10 A medicinal product shall not be a prescription only medicine by reason that it contains the substance budesonide, where – (a) the medicinal product is in non-aerosol, aqueous form for nasal administration; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 10 mg of the medicinal product; (c) the container or package is labelled to show a maximum dose, and a maximum daily dose, of 200 mcg per nostril of budesonide; and (d) the medicinal product is indicated only for the prevention of treatment of seasonal allergic rhinitis, in persons aged not less than 12 years. 11 A medicinal product shall not be a prescription only medicine by reason that it contains the substance carbenoxolone sodium, where – (a) the medicinal product is in the form of granules; (b) the maximum strength of the carbenoxolone sodium in the medicinal product does not exceed 1%, calculated in terms of weight in weight; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 560 mg of carbenoxolone sodium; (d) the container or package is labelled to show a maximum dose of 20 mg and a maximum daily dose of 80 mg of carbenoxolone sodium; and (e) the medicinal product is indicated only for treatment by mouthwash, in persons aged not less than 12 years. 12 A medicinal product shall not be a prescription only medicine by reason that it contains the substance cetirizine, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 100 mg of cetirizine; and (b) the container or package is labelled to show a maximum daily dose of 10mg of cetirizine. 13 A medicinal product shall not be a prescription only medicine by reason that it contains the substance cimetidine, where – (a) the container or package in which the medicinal product is sold or supplied is labelled to show a maximum dose of 200 mg and a maximum daily dose of 800 mg of cimetidine for a maximum period of 14 days; and (b) the medicinal product is indicated for the short-term symptomatic relief of heartburn, dyspepsia and hyperacidity and for the prophylaxsis of meal-induced heartburn.

Page - 74 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

14 A medicinal product shall not be a prescription only medicine by reason that it contains the substance cimetidene, where – (a) the medicinal product is for the prophylactic management of nocturnal heartburn; and (b) the container or package in which the medicinal product is sold or supplied is labelled to show a maximum dose of 100 mg of cimetidine to be taken once daily at night for a maximum period of 14 days. 15 A medicinal product shall not be a prescription only medicine by reason that it contains the substance , where – (a) the medicinal product is in the form of a cream; (b) the maximum strength of the clobetasone butyrate in the medicinal product does not exceed 0.05%; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 15 g of the medicinal product; and (d) the medicinal product is indicated only for external application for the short-term treatment of eczema and dermatitis, in persons aged not less than 12 years. 16 A medicinal product shall not be a prescription only medicine by reason that it contains the substance diclofenac diethylammonium, where – (a) the maximum strength of the diclofenac diethylammonium in the medicinal product does not exceed 1.16%, calculated in terms of weight in weight; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 30 g of the medicinal product; (c) the container or package is labelled to show a maximum period of use of 7 days; and (d) the medicinal product is indicated for external application for the local symptomatic relief of pain and inflammation in trauma of the tendons, ligaments, muscles and joints and in localized forms of soft tissue rheumatism, in persons aged not less than 12 years. 17 A medicinal product shall not be a prescription only medicine by reason that it contains the substance domperidone, where – (a) the medicinal product is indicated for the relief of post-prandial symptoms of excessive fullness, nausea, epigastric bloating and belching, occasionally accompanied by epigastric discomfort and heartburn; (b) the medicinal product is sold or supplied in a container or package containing not more than 200 mg of domperidone; and (c) the container or package is labelled to show a maximum dose of 10 mg of domperidone and a maximum daily dose of 40 mg of domperidone. 18 A medicinal product shall not be a prescription only medicine by reason that it contains the substance domperidone maleate, where –

Revised Edition – 1 January 2019 Page - 75 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

(a) the medicinal product is sold in a container, or package, containing not more than 200 mg of domperidone maleate; (b) the container or package is labelled to show a maximum dose of 10 mg and a maximum daily dose of 40 mg; and (c) the medicinal product is indicated for use for the relief of postprandial symptoms of excessive fullness, nausea, epigastric bloating and belching, accompanied by epigastric discomfort and heartburn. 19 A medicinal product shall not be a prescription only medicine by reason that it contains the substance famotidine, where – (a) the container or package in which the medicinal product is sold or supplied is labelled to show a maximum dose of 10 mg and a maximum daily dose of 20 mg of famotidine for a maximum period of 14 days; and (b) the medicinal product is indicated for – (i) the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion or hyperacidity, or (ii) the prevention of the symptoms of heartburn, dyspepsia, indigestion, acid indigestion or hyperacidity where they are associated with the consumption of food or drink, including the prevention of sleep disturbance because of those symptoms. 20 A medicinal product shall not be a prescription only medicine by reason that it contains the substance felbinac, where – (a) the maximum strength of the felbinac in the medicinal product does not exceed 3.17%, calculated in terms of weight in weight; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 50 g of the medicinal product; (c) the container or package is labelled to show a maximum period of use of 7 days; and (d) the medicinal product is indicated for external application for the relief of symptoms associated with soft tissue injury such as strains, sprains and contusions, in persons aged not less than 12 years. 21 A medicinal product shall not be a prescription only medicine by reason that it contains the substance fluconazole, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 150 mg of the medicinal product; (b) the container or package is labelled to show a maximum dose of 150 mg of fluconazole; and (c) the medicinal product is indicated for oral administration for the treatment of vaginal candidiasis or associated candidal balanitis, in persons aged not less than 16 years but less than 60 years. 22 A medicinal product shall not be a prescription only medicine by reason that it contains the substance flunisolide, where –

Page - 76 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

(a) the medicinal product is in the form of a non-pressurized nasal spray; (b) the maximum strength of the flunisolide in the medicinal product does not exceed 0.025%, calculated in terms of weight in volume; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 240 metered doses of the medicinal product; (d) the container or package is labelled to show a maximum dose of 50 mcg per nostril and a maximum daily dose of 100 mcg per nostril of flunisolide in the case of persons aged not less than 16 years, and a maximum dose of 25 mcg per nostril and a maximum daily dose of 75 mcg per nostril in the case of children aged not less than 12 years but less than 16 years; and (e) the medicinal product is indicated for the prevention and treatment of seasonal allergenic rhinitus, including hay fever, in persons aged not less than 12 years. 23 A medicinal product shall not be a prescription only medicine by reason that it contains the substance hydrocortisone, where – (a) the maximum strength of the hydrocortisone in the medicinal product does not exceed 0.5%, calculated in terms of weight in weight; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 15 g of the medicinal product; and (c) the medicinal product is indicated for external use in combination with nystatin of a maximum strength of 3.0%, for intertrigo, in persons aged not less than 10 years. 24 A medicinal product shall not be a prescription only medicine by reason that it contains the substance hydrocortisone, where – (a) the medicinal product is in the form of a cream, ointment or spray; (b) the maximum strength of the hydrocortisone in the medicinal product does not exceed 1.0%, calculated in terms of weight in weight; (c) the medicinal product is sold or supplied in a container, or package, containing – (i) where the medicinal product is in the form of a cream or ointment, not more than 15 g of the medicinal product, or (ii) where the medicinal product is in the form of a spray, not more than 30 ml of the medicinal product; (d) the medicinal product is indicated for external use, either alone or in conjunction with crotamiton in irritant dermatitis, contact allergic dermatitis, insect bite reactions or mild to moderate eczema, and either in combination with clotrimazole or miconazole nitrate for athlete’s foot and candidal intertrigo or in combination with lignocaine for anal and perianal itch associated with haemorrhoids; and

Revised Edition – 1 January 2019 Page - 77 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

(e) the medicinal product is indicated for use in persons aged not less than 10 years. 25 A medicinal product shall not be a prescription only medicine by reason that it contains the substance hydrocortisone acetate, where – (a) the medicinal product is in the form of a cream or ointment, or suppositories; (b) the maximum strength of the hydrocortisone acetate in the medicinal product is equivalent to 1.0% of hydrocortisone, calculated in terms of weight in weight; (c) the medicinal product is sold or supplied in a container, or package, containing – (i) where the medicinal product is in the form of a cream or ointment, not more than 15 g of the medicinal product, or (ii) where the medicinal product is in the form of suppositories, not more than 12 suppositories; (d) the medicinal product is indicated for external use - (i) for irritant dermatitis, contact allergic dermatitis, insect bite reactions or mild to moderate eczema, (ii) in combination with one or more of the following, namely benzyl benzoate, bismuth oxide, bismuth subgallate, peru balsam, pramoxine hydrochloride and zinc oxide, for haemorrhoids, or (iii) in combination with miconazole nitrate, for tinea pedis or candidal intertrigo; and (e) the medicinal product is indicated for use in persons aged not less than 10 years. 26 A medicinal product shall not be a prescription only medicine by reason that it contains the substance hydrocortisone sodium succinate, where – (a) the medicinal product is in the form of pellets; (b) the maximum strength of the hydrocortisone sodium succinate in the medicinal product is equivalent to 2.5 mg of hydrocortisone, calculated in terms of weight in weight; (c) the medicinal product is sold or supplied in a container, or package, containing the equivalent of 50 mg of hydrocortisone; and (d) the medicinal product is indicated for external use for aphthous ulceration of the mouth, in persons aged not less than 12 years. 27 A medicinal product shall not be a prescription only medicine by reason that it contains the substance hydroxyzine hydrochloride, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 750 mg of the medicinal product; (b) the container or package is labelled to show a maximum dose of 25 mg, and to show a maximum daily dose of 75 mg in the case of persons aged not less than 12 years and a maximum daily dose of 50 mg in the case of children aged not less than 6 years but less than 12 years; and

Page - 78 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

(c) the medicinal product is indicated for the management of pruritus associated with acute or chronic urticaria or atopic dermatitis or contact dermatitis, in persons aged not less than 6 years. 28 A medicinal product shall not be a prescription only medicine by reason that it contains the substance hyoscine butylbromide, where – (a) the route of administration of the medicinal product is internal and is otherwise than by means of an inhaler; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 240 mg of the medicinal product; and (c) the container or package is labelled to show a maximum dose of 20 mg and a maximum daily dose of 80 mg of the medicinal product. 29 A medicinal product shall not be a prescription only medicine by reason that it contains the substance Ibuprofen, where – (a) the medicinal product is indicated for the relief of rheumatic and muscular pain, pain of non-serious arthritic conditions, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza; and either (b) the route of the administration of the medicinal product is internal; and – (i) in the case of a prolonged release preparation the container or package is labelled to show a maximum dose of 600 mg and a maximum daily dose of 1200 mg, or (ii) in any other case the container or package is labelled to show a maximum dose of 400 mg and a maximum daily dose of 1200 mg; or (c) the route of administration of the medicinal product is external; and (i) the maximum strength of the Ibuprofen in the medicinal product does not exceed 5%, or (ii) (A) the maximum strength of the Ibuprofen in the medicinal product does not exceed 10%, and (B) the medicinal product is sold or supplied in a container or package containing not more than 50 g of medicinal product which is labelled to show a maximum dose of 125 mg and a maximum daily dose of 500 mg. 30 A medicinal product shall not be a prescription only medicine by reason that it contains the substance ketoconazole, where – (a) the medicinal product is in the form of a shampoo; (b) the maximum strength of the ketoconazole in the medicinal product does not exceed 2%, calculated in terms of weight in weight; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 120 ml of the medicinal product

Revised Edition – 1 January 2019 Page - 79 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

and containing in the medicinal product not more than 2,400 mg of ketoconazole; (d) the container or package is labelled to show a maximum frequency of application of once every 3 days; and (e) the medicinal product is indicated for the prevention and treatment of dandruff and of the scalp. 31 A medicinal product shall not be a prescription only medicine by reason that it contains the substance ketoprofen, where – (a) the maximum strength of the ketoprofen in the medicinal product does not exceed 2.5%, calculated in terms of weight in weight; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 30 g of the medicinal product; and (c) the medicinal product is indicated only for treatment by external topical application, for rheumatic and muscular pain, in persons aged not less than 12 years, for a maximum period of 7 days. 32 A medicinal product shall not be a prescription only medicine by reason that it contains the substance levocabastine hydrochloride, where – (a) the medicinal product is in the form of a nasal spray; (b) the maximum strength of the medicinal product does not exceed the equivalent of 0.05% levocabastine; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 10 ml of the medicinal product; and (d) the medicinal product is indicated for the symptomatic treatment of seasonal allergic rhinitis. 33 A medicinal product shall not be a prescription only medicine by reason that it contains the substance levocabastine hydrochloride, where – (a) the medicinal product is in the form of aqueous eye drops; (b) the maximum strength of the medicinal product does not exceed the equivalent of 0.05% levocabastine; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 4ml of the medicinal product; and (d) the medicinal product is indicated for the symptomatic treatment of seasonal allergic conjunctivitis. 34 A medicinal product shall not be a prescription only medicine by reason that it contains the substance loratadine, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 100 mg of loratadine; and (b) the container or package is labelled to show a maximum daily dose of 10 mg of loratadine. 35 A medicinal product shall not be a prescription only medicine by reason that it contains the substance mebendazole, where –

Page - 80 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

(a) the medicinal product is sold or supplied in a container, or package, containing not more than 800 mg of mebendazole; (b) the container or package is labelled to show a maximum dose of 100 mg of mebendazole; and (c) the medicinal product is indicated for oral use in the treatment of enterobiasis, in persons aged not less than 2 years. 36 A medicinal product shall not be a prescription only medicine by reason that it contains the substance nedocromil sodium, where – (a) the maximum strength of the nedocromil sodium in the medicinal product does not exceed 2.0%, calculated in terms of weight in volume; (b) the medicinal product is sold in a container, or package, containing not more than 3 ml of the medicinal product; and (c) the medicinal product is indicated for the prevention, relief and treatment of seasonal and perennial allergic conjunctivitis. 37 A medicinal product shall not be a prescription only medicine by reason that it contains the substance nizatidine, where – (a) the container or package in which the medicinal product is sold or supplied is labelled to show a maximum dose of 75 mg of nizatidine and a maximum of 4 such doses in any period of 14 days; and (b) the medicinal product is indicated only for the prevention of the symptoms of food-related heartburn, in persons aged not less than 16 years. 38 A medicinal product shall not be a prescription only medicine by reason that it contains the substance nystatin, where – (a) the maximum strength of the nystatin in the medicinal product does not exceed 3.0%, calculated in terms of weight in weight; (b) the medicinal product is sold in a container, or package, containing not more than 15 g of the medicinal product; and (c) the medicinal product is indicated for external use in combination with hydrocortisone of a maximum strength of 0.5% for intertrigo, in persons aged not less than 10 years. 39 A medicinal product shall not be a prescription only medicine by reason that it contains the substance oxethazaine, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 400 ml of oxethazaine; and (b) the container or package is labelled to show a maximum dose of 10 ml and a maximum daily dose of 30 ml of oxethazaine. 40 A medicinal product shall not be a prescription only medicine by reason that it contains the substance paracetamol, where – (a) the medicinal product is in the form of non-effervescent tablets or capsules;

Revised Edition – 1 January 2019 Page - 81 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

(b) the maximum strength of the medicinal product in each tablet or capsule does not exceed 500 mg; (c) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied in one container or package does not exceed 32; (d) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied to a person at any one time does not exceed 100; and (e) the medicinal product is indicated for use by administration wholly or mainly to persons aged not less than 12 years. 41 A medicinal product shall not be a prescription only medicine by reason that it contains the substance paracetamol, where – (a) the medicinal product is in the form of non-effervescent tablets or capsules; (b) the maximum strength of the medicinal product in each tablet or capsule does not exceed 250 mg; (c) the quantity (of tablets or capsules, or of any combination of tablets and capsules) that is sold or supplied in one container or package does not exceed 32; and (d) the quantity (of tablets and capsules, or of any combination of tablets and capsules) that is sold or supplied to a person at any one time does not exceed 100. 42 A medicinal product shall not be a prescription only medicine by reason that it contains the substance piroxicam, where – (a) the maximum strength of the piroxicam in the medicinal product does not exceed 0.5%; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 30 mg of the medicinal product; (c) the container or package is labelled to show a maximum period of use of 7 days; and (d) the medicinal product is indicated for external application for the relief of rheumatic pain, pain of non-serious arthritic conditions and muscular aches, pains and swellings such as strains, sprains and sports injuries, in persons aged not less than 12 years. 43 A medicinal product shall not be a prescription only medicine by reason that it contains the substance prochlorperazine maleate, where – (a) the medicinal product is in the form of tablets; (b) the maximum amount of the prochlorperazine maleate in the medicinal product, in each tablet, does not exceed 3 mg; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 8 tablets; and (d) the medicinal product is indicated only for nausea, and vomiting, in previously diagnosed migraine, in persons aged not less than 18 years.

Page - 82 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 1

44 A medicinal product shall not be a prescription only medicine by reason that it contains the substance pyrantel embonate, where – (a) the medicinal product is sold or supplied in a container, or package, containing not more than 750 mg of the medicinal product; (b) the container or package is labelled to show a maximum daily dose (to be taken as a single dose) of pyrantel embonate of 750 mg in the case of persons aged not less than 12 years, of 500 mg in the case of children aged not less than 6 years but less than 12 years, and of 250 mg in the case of children aged not less than 2 years but less than 6 years; and (c) the medicinal product is indicated for the treatment of enterobiasis, in persons aged not less than 2 years. 45 A medicinal product shall not be a prescription only medicine by reason that it contains the substance ranitidine hydrochloride, where – (a) the container or package in which the medicinal product is sold or supplied is labelled to show a maximum dose equivalent to 75 ml and a maximum daily dose equivalent to 300 ml of ranitidine for a maximum period of use of 14 days; and (b) the medicinal product is indicated for the short-term symptomatic relief of heartburn, dyspepsia and hyperacidity, or the prevention of those symptoms when associated with the consumption of food and drink. 46 A medicinal product shall not be a prescription only medicine by reason that it contains the substance sodium cromoglycate, where – (a) the medicinal product is in the form of aqueous eye drops; (b) the maximum strength of the sodium cromoglycate in the medicinal product does not exceed 2%, calculated in terms of weight in volume; (c) the medicinal product is sold or supplied in a container containing not more than 10 ml of the medicinal product; and (d) the medicinal product is indicated for treatment of acute seasonal allergic conjunctivitis. 47 A medicinal product shall not be a prescription only medicine by reason that it contains the substance sodium cromoglycgate, where – (a) the medicinal product is in the form of an eye ointment; (b) the maximum strength of the sodium cromoglycate in the medicinal product is 4%, calculated in terms of weight in weight; (c) the medicinal product is sold or supplied in a container, or package, containing not more than 5 g of the medicinal product; and (d) the medicinal product is indicated for the treatment of acute seasonal allergic conjunctivitis or perennial allergic conjunctivitis. 48 A medicinal product shall not be a prescription only medicine by reason of the fact that it contains terbinafine, where –

Revised Edition – 1 January 2019 Page - 83 20.625.95

SCHEDULE 1 Medicines (Prescription Only) (Jersey) Order 1997

(a) the maximum strength of the terbinafine in the medicinal product does not exceed 1%; (b) the medicinal product is sold or supplied in a container, or package, containing not more than 30 g of the medicinal product; and (c) the medicinal product is indicated for external use as a gel for the treatment of tina corporis, tinea pedis and tinea cruris. 49 A medicinal product shall not be a prescription only medicine by reason of the fact that it contains terbinafine hydrochloride where – (a) the maximum strength of the terbinafine hydrochloride in the medicinal product does not exceed 1%; (b) the medicinal product is indicated for external use for the treatment of tinea pedis and tinea cruris; and (c) the medicinal product is sold or supplied in a container or package containing not more than 15 g of medicinal product. 50 A medicinal product shall not be a prescription only medicine by reason of the fact that it contains terbinafine hydrochloride, where – (a) the maximum strength of the terbinafine hydrochloride in the medicinal product does not exceed 1%; (b) the medicinal product is sold or supplied in a container containing not more than 30 ml of the medicinal product; and (c) the medicinal product is indicated for external use as a spray solution for the treatment of tina corporis, tinea pedis and tinea cruris. 51 A medicinal product shall not be a prescription only medicine by reason of the fact that it contains triamcinolone acetonide where – (a) the medicinal product is in the form of a non-pressurised nasal spray; (b) the medicinal product is indicated for the treatment of symptoms of seasonal allergic rhinitis in persons aged 18 years and over for a maximum period of 3 months; (c) the container or package is labelled to show a maximum dose of 110 mcg per nostril and a maximum daily dose of 110 mcg per nostril; and (d) the medicinal product is sold or supplied in a container or package containing not more than 3.375 mg of triamcinolone acetonide.

Page - 84 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 2

SCHEDULE 2

EXEMPTION FOR CERTAIN PERSONS FROM ARTICLE 57(2) OF THE LAW

PART 129

(Articles 1(2)(a) and 8(1))

Column 1 Column 2 Column 3 Persons exempted Prescription only Conditions medicines to which the exemption applies 1. Persons selling or 1. All prescription only 1.(1) The sale or supply supplying prescription only medicines. shall be subject to the medicines to universities, presentation of an order, other institutions concerned signed by the principal of with higher education or the institution or the institutions concerned with appropriate head of research. department in charge of a specified course of research. (2) The order shall specify– (a) the name of the institution for which the prescription only medicine is required; (b) the purpose for which the prescription only medicine is required; and (c) the total quantity required. (3) The sale or supply shall be only for the purposes of the education or research with which the institution is concerned. 2. Persons selling or 2. All prescription only 2.(1) The sale or supply supplying prescription only medicines. shall be subject to the medicines to any of the presentation of an order following persons – signed by or on behalf of (a) the Official Analyst any person listed in any of appointed under Article 2 paragraph 2(a), (b) and (c) of the Food Safety (Jersey) of column 1 of this Part of Law 196630, or any person this Schedule. appointed under that (2) The order shall specify Article to deputise for him the status of the person

Revised Edition – 1 January 2019 Page - 85 20.625.95

SCHEDULE 2 Medicines (Prescription Only) (Jersey) Order 1997

Column 1 Column 2 Column 3 Persons exempted Prescription only Conditions medicines to which the exemption applies or her; signing it, and the amount of the prescription only medicine required. (b) an authorized officer (3) The sale or supply shall within the meaning of the be only in connection with Food Safety (Jersey) the exercise by the person Law 196631; and of his or her statutory functions. (c) a person duly authorized by the Minister under Article 96 or 97 of the Law. 3. Persons selling or 3. All prescription only 3.(1) The sale or supply supplying prescription only medicines. shall be subject to the medicines to any person presentation of an order employed or engaged in signed by or on behalf of connection with a scheme the person so employed or for testing the quality and engaged. checking the amount of (2) The order shall specify drugs and appliances the status of the person supplied under the Health signing it, and the amount Insurance (Jersey) of the prescription only Law 196732, or under any medicine required. subordinate legislation made under that law. (3) The sale or supply shall be only for the purposes of a scheme to which paragraph 3 of column 1 of this Part of this Schedule refers. 4. Certified midwives. 4. Prescription only 4. The sale or supply shall medicines containing any be only in the course of the of the following midwife’s professional substances – practice and, in the case of Chloral hydrate Ergometrine maleate, only Dichloral-phenazone when contained in a Ergometrine maleate medicinal product that is hydrochloride not for parenteral Phytomenadrone administration. Triclofos sodium 5. Persons lawfully 5. Prescription only 5. The sale or supply shall conducting retail pharmacy medicines (not being for be subject to the businesses. parenteral administration) presentation of an order that are of any of the signed by a registered following descriptions – optometrist. (a) eye drops, or eye ointments, that are

Page - 86 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 2

Column 1 Column 2 Column 3 Persons exempted Prescription only Conditions medicines to which the exemption applies prescription only medicines by reason only that they contain – (i) 30.0% Sulphacetamide sodium; or (ii) 0.5% Chloramphenicol; (b) eye ointments that are prescription only medicines by reason only that they contain – (i) 30.0% Sulpha-cetamide sodium; or (ii) 0.5%Chloramphenicol; or (c) medicinal products that are prescription only medicines by reason only that they contain any of the following substances – Atropine sulphate Bethanecol chloride Carbachol Cyclopentolate hydrochloride Homatropine hydrobromide Hyoscine hydrobromide Naphazoline hydrochloride Naphazoline nitrate Neostigmine methyl- sulphate Physostigmine salicylate Physostigmine sulphate Pilocarpine hydrochloride Pilocarpine nitrate Tropicamide.

6. Registered optometrists. 6. Prescription only 6.(1) The sale or supply medicines listed in shall be only in the course paragraph 5 of column 2 of of the optician’s this Part of this Schedule. professional practice. (2) The sale shall be only in an emergency. 7.(1) Holders of product 7. Prescription only 7. The sale or supply shall

Revised Edition – 1 January 2019 Page - 87 20.625.95

SCHEDULE 2 Medicines (Prescription Only) (Jersey) Order 1997

Column 1 Column 2 Column 3 Persons exempted Prescription only Conditions medicines to which the exemption applies licences. medicines to which the be only – licence relates. (2) Holders of (a) to a pharmacist, so as to manufacturer’s licences. enable that pharmacist to prepare an entry relating to the prescription only medicine in question in a tablet or capsule identifi- cation guide or similar publication; and (b) of no greater quantity than is reasonably necessary for that purpose. 8. Pharmacists selling or 8. Amyl nitrite. 8. The sale or supply shall supplying to persons to only be so far as is whom cyanide salts may be necessary to enable an sold lawfully under the antidote to be available to Poisons (Jersey) persons at risk of cyanide Law 195233. poisoning.

Page - 88 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 2

PART 2

(Articles 1(2) and 8(1))

Column 1 Column 2 Column 3 Persons exempted Prescription only Conditions medicines to which the exemption applies 1.(1) The Royal National 1. All prescription only 1. The supply shall be Lifeboat Institution. medicines. only so far as is (2) Certificated first aiders of necessary for the the Institution. treatment of sick or injured persons. 2. The owner or the master of a 2. All prescription only 2. The supply shall be ship that does not carry a doctor medicines. only so far as is on board as part of the ship’s necessary for the complement. treatment of persons on the ship. 3. The operator or commander 3. Prescription only 3.(1) The supply shall be of an aircraft. medicines that – only so far as is (a) are not for parenteral necessary for the administration; and immediate treatment of (b) have been sold or sick or injured persons supplied to the operator on the aircraft. or commander of the (2) The supply shall be in aircraft in response to an accordance with the order in writing signed written instructions of a by a doctor. doctor as to the circumstances in which prescription only medicines of the description in question are to be used on the aircraft. 4. Persons authorized by 4. Prescription only 4. The supply shall be licences granted under Article 4 medicines (being subject to the conditions, of the Misuse of Drugs controlled drugs) whose in the circumstances and (General Provisions) (Jersey) supply is authorized by to the extent specified in Order 198934 to supply a the licence. the licence. controlled drug.

Revised Edition – 1 January 2019 Page - 89 20.625.95

SCHEDULE 2 Medicines (Prescription Only) (Jersey) Order 1997

Column 1 Column 2 Column 3 5. Persons requiring 5. Prescription only 5.(1) The supply shall be prescription only medicines to medicines specified in only to enable the person enable them, in the course of the enactment. to comply with any such any business carried on by requirements. them, to comply with any (2) The supply shall be requirements under any subject to such enactment in respect of the conditions and in such medical treatment of their circumstances as may be employees. specified in the enactment. 6. Persons operating an 6. Prescription only 6.(1) The supply shall be occupational health scheme. medicines sold or only in the course of the supplied to such a scheme. person in response to an (2) The person supplying order in writing signed the prescription only by a doctor or a medicine shall be – registered nurse. (a) a doctor; or

(b) a registered nurse acting in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used in the course of the scheme.

Page - 90 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 2

PART 335

(Articles 1(2) and 8(2))

Column 1 Column 2 Column 3 Persons exempted Prescription only Conditions medicines to which the exemption applies 1. Chiropodists, registered 1. Prescription only 1. The administration shall under the Health Care medicines for parenteral be only in the course of the (Registration) (Jersey) administration that contain, chiropodist’s professional Law 199536, who hold as the sole active practice. certificates of competence ingredient, not more than in the use of analgesics one of the following issued by or with the substances – approval of the Chiropodists Board of the United Kingdom. Bupivacaine hydrochloride Bupivacaine hydrochloride with adrenaline, where the maximum strength of the adrenaline does not exceed 1 mg in 200 ml of bupivacaine hydrochloride Lignocaine hydrochloride Lignocaine hydrochloride with adrenaline, where the maximum strength of the adrenaline does not exceed 1 mg in 200 ml of lignocaine hydrochloride Mepivacaine hydrochloride Prilocaine hydrochloride 2. Certified midwives. 2. Prescription only 2. The administration shall medicines for parenteral be only in the course of the administration that contain midwife’s professional any of the following practice and, in the case of substances (but no other Lignocaine, Lignocaine substance specified in hydrochloride and column 1 of Part I of the Promazine hydrochloride, First Schedule to this shall be only while Order) – attending on a woman in childbirth. Ergometrine maleate Levallorphan tartrate Lignocaine Lignocaine hydrochloride Naloxone hydrochloride

Revised Edition – 1 January 2019 Page - 91 20.625.95

SCHEDULE 2 Medicines (Prescription Only) (Jersey) Order 1997

Column 1 Column 2 Column 3 Oxytocins, Natural and Synthetic Pentazocine lactate Pethidine hydrochloride Phytomenadione Promazine hydrochloride. 3. The owner or the master 3. All prescription only 3. The administration shall of a ship that does not medicines that are for be only so far as is carry a doctor on board as parenteral administration. necessary for the treatment part of the ship’s of persons on the ship. complement. 4. The operator or 4. Prescription only 4.(1) The administration commander of an aircraft. medicines for parenteral shall be only so far as is administration that have necessary for the been sold or supplied to the immediate treatment of operator or commander of sick or injured persons on the aircraft in response to the aircraft. an order in writing signed by a doctor. (2) The administration shall be in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used on the aircraft. 5. Persons operating an 5. Prescription only 5.(1) The administration occupational health medicines for parenteral shall be only in the course scheme. administralion that have of the scheme. been sold or supplied to (2) The person such a person in response administering the to an order in writing prescription only medicine signed by a doctor or a shall be – registered nurse (a) a doctor; (b) a person acting in accordance with the directions of a doctor; or (c) a registered nurse acting in accordance with the written instructions of a doctor as to the circumstances in which prescription only medicines of the description in question are to be used in the course of the scheme.

Page - 92 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 2

Column 1 Column 2 Column 3 6. Persons who hold 6. The following 6. The administration shall certificates of proficiency prescription only be only for the immediate, in ambulance paramedical medicines for parenteral necessary treatment of sick skills issued by or with the administration – or injured persons and, in approval of the Secretary the case of a prescription of State of the United only medicine containing Kingdom, or persons who Heparin sodium, shall be are state registered only for the purpose of paramedics. cannula flushing. (a) Diazemuls (product licence number 10183/00001); (b) Gelofusine (product licence number 00183/5025R); and (c) medicines containing the substances Ergometrine Maleate 500mcg per ml with Oxytocin 5 iu per ml, but no other active ingredient: (d) prescription only medicines that contain one or more of the following substances, (but no other active ingredient)- Adrenaline acid tartrate Benzylpenicillin Frusemide Glucose Heparin sodium Lignocaine hydrochloride Metoclopramide Morphine Sulphate Nalbuphine hydrochloride Naloxone hydrochloride Polygeline Sodium bicarbonate Sodium chloride. Streptokinase

Revised Edition – 1 January 2019 Page - 93 20.625.95

SCHEDULE 3 Medicines (Prescription Only) (Jersey) Order 1997

SCHEDULE 3

(Articles 9(3)(c) and (4)(a))

SUBSTANCES THAT MUST NOT BE CONTAINED IN A PRESCRIPTION ONLY MEDICINE EXEMPTED BY ARTICLE 9

Ammonium Bromide Amylobarbitone Amylobarbitone Sodium Barbitone Barbitone Sodium Butobarbitone Butobarbitone Sodium Calcium Bromide Calcium Bromidolactobionate Cyclobarbitone Cyclobarbitone Calcium Embutramide Fencamfamin Hydrochloride Fluanisone Heptabarbitone Hexobarbitone Hexobarbitone Sodium Hydrobromic Acid Meclofenoxate Hydrochloride Methohexitone Sodium Methylphenobarbitone Pemoline Pentobarbitone Pentobarbitone Sodium Phenobarbitone Phenobarbitone Sodium Phenylmethylbarbituric Acid Piracetam Potassium Bromide Prolintane Hydrochloride Quinalbarbitone Quinalbarbitone Sodium Quinidine Phenylethylbarbiturate Secbutobarbitone Secbutobarbitone Sodium Sodium Bromide Strychnine Hydrochloride Tacrine Hydrochloride Thiopentone Sodium Note (for information): The restriction in Article 9(3)(c) is subject to Article 9(4), in respect of Phenobarbitone and Phenobarbitone Sodium for use in the treatment of epilepsy.

Page - 94 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 SCHEDULE 4

SCHEDULE 437

(Articles 6(2)(ca) and 6A(2))

CLINICAL MANAGEMENT PLAN

1 Information to be included in clinical management plan A clinical management plan must include – (a) the name of the patient to whom the plan relates; (b) the illness or conditions in relation to which the supplementary prescriber may give a prescription or administer (or direct the administration of) a medicinal product; (c) the date on which the plan is to take effect and the date or dates when it is subject to review by the doctor or dentist who is a party to the plan; (d) the class or description of medicinal product that may be prescribed by a supplementary prescriber or administered by, or under the direction of, a supplementary prescriber; (e) any restrictions or limitations as to the strength or dose, or period of use, of any medicinal product which may be prescribed by or administered by, or under the direction of, the supplementary prescriber; (f) any relevant warnings about the known sensitivities of the patient to, or known difficulties of the patient with, particular medicinal products; (g) arrangements for the notification of suspected or known adverse reactions to – (i) the medicinal product referred to in paragraph (d), and (ii) any other medicinal product taken at the same time or over the same period; (h) the circumstances in which the supplementary prescriber should refer to, or seek the advice of, the doctor or dentist who is a party to the plan.

Revised Edition – 1 January 2019 Page - 95 20.625.95

Endnotes Medicines (Prescription Only) (Jersey) Order 1997

ENDNOTES

Table of Legislation History

Legislation Year and No Commencement Medicines (Prescription Only) R&O.9140 1 January 1998 (Jersey) Order 1997 Medicines (Prescription Only) R&O.9326 1 January 1999 (Amendment) (Jersey) Order 1998 Medicines (Prescription Only) R&O.1/2000 1 February 2000 (Amendment No. 2) (Jersey) Order 2000 Medicines (Prescription Only) R&O.2/2001 1 February 2001 (Amendment No. 3) (Jersey) Order 2001 Medicines (Prescription Only) R&O.94/2002 1 October 2002 (Amendment No. 4) (Jersey) Order 2002 Medicines (Prescription Only) R&O.75/2003 13 August 2003 (Amendment No. 5) (Jersey) Order 2003 Medicines (Prescription Only) R&O.65/2004 12 July 2004 (Amendment No. 6) (Jersey) Order 2004 Medicines (Prescription Only) R&O.174/2005 11 November 2005 (Amendment No. 7) (Jersey) Order 2005 States of Jersey (Amendments R&O.45/2005 9 December 2005 and Construction Provisions No. 5) (Jersey) Regulations 2005 Pharmacists and Pharmacy L.6/2010 16 May 2010 Technicians (Registration) (Jersey) Law 2010 Medicines (Prescription Only) R&O.82/2013 1 July 2013 (Amendment No. 8) (Jersey) Order 2013 Opticians (Registration) L.13/2017 19 May 2017 (Amendment No.2) (Jersey) Law 2017 Data Protection (Jersey) Law L.3/2018 25 May 2018 2018

Table of Renumbered Provisions

Original Current 3(3) revoked by R&O.9326 10A 11 11 12

Page - 96 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Endnotes

Original Current 12 13 13 14 14 15 15 16 FIRST SCHEDULE SCHEDULE 1 PART I PART 1 PART II PART 2 PART III PART 3 PART IV PART 4 7A 8 8 9 9 10 10 11 11 12 12 13 13 14 13A 15 14 16 14A 17 15 18 16 19 17 20 18 21 19 22 20 23 21 24 22 25 23 26 24 27 25 28 25A 29 26 30 27 31 28 32 29 33 30 34 31 35 32 36 33 37 34 38 35 39 36 40 37 41 38 42 38A 43 39 44 40 45 41 46

Revised Edition – 1 January 2019 Page - 97 20.625.95

Endnotes Medicines (Prescription Only) (Jersey) Order 1997

Original Current 42 47 42A 48 43 49 43A 50 44 51 SECOND SCHEDULE SCHEDULE 2 PART I PART 1 PART II PART 2 PART III PART 3 6(bb) 6(c) 6(c) 6(d) THIRD SCHEDULE SCHEDULE 3

Table of Endnote References

1 This Order has been amended by the States of Jersey (Amendments and Construction Provisions No. 5) (Jersey) Regulations 2005. The amendments replace all references to a Committee of the States of Jersey with a reference to a Minister of the States of Jersey, and remove and add defined terms appropriately, consequentially upon the move from a committee system of government to a ministerial system of government 2 chapter 20.625 3 chapter 08.680 4 chapter 26.500 5 L.3/2018 6 chapter 20.625 7 chapter 20.750 8 chapter 20.300.50 9Article 1(1) amended by R&O.2/2001, R&O.82/2013, L.13/2017, L.3/2018 10 chapter 15.360 11 chapter 20.625 12 Article 2 amended by R&O.82/2013 13 Article 5 substituted by R&O.82/2013 14 chapter 20.300 15 Article 6 heading amended by R&O.82/2013 16 chapter 08.680.60 17 Article 6(2) amended by R&O.82/2013 18 Article 6A inserted by R&O.82/2013 19 chapter 08.680.60 20 chapter 20.625.80 21 chapter 08.680.60 22 chapter 20.625.80 23 Article 9(3) amended by R&O.9326, R&O.1/2000 24 chapter 08.680.60 25 Article 10 substituted by R&O.82/2013 26 Article 11 inserted by R&O.65/2004 27 Schedule 1 Part 1 amended by R&O.9326, R&O.1/2000, R&O.2/2001, R&O.94/2002, R&O.174/2005 28 Schedule 1 Part 4 substituted by R&O.1/2000, amended by R&O.2/2001, R&O.94/2002, 29 Schedule 2 Part 1 amended by R&O.1/2000, L.6/2010, L.13/2017 30 chapter 20.225 31 chapter 20.225

Page - 98 Revised Edition – 1 January 2019 20.625.95

Medicines (Prescription Only) (Jersey) Order 1997 Endnotes

32 chapter 26.500 33 chapter 20.775 34 chapter 08.680.60 35 Schedule 2 Part 3 amended by R&O.9326, R&O.1/2000, R&O.2/2001 36 chapter 20.300 37 Schedule 4 inserted by R&O.82/2013

Revised Edition – 1 January 2019 Page - 99 20.625.95